

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Leishmaniasis: a review | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-750/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-750" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Leishmaniasis: a review" />
    
            <meta name="og:title" content="F1000Research Article: Leishmaniasis: a review.">
            <meta name="og:description" content="Read the latest article version by Edoardo Torres-Guerrero, Marco Romano Quintanilla-Cedillo, Julieta Ruiz-Esmenjaud, Roberto Arenas, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="11996">
            <meta name="article-id" content="11120">
            <meta name="dc.title" content="Leishmaniasis: a review">
            <meta name="dc.description" content="Leishmaniasis is caused by an intracellular parasite transmitted to humans by the bite of a sand fly. It is endemic in Asia, Africa, the Americas, and the Mediterranean region. Worldwide, 1.5 to 2 million new cases occur each year, 350 million are at risk of acquiring the disease, and leishmaniasis causes 70,000 deaths per year. Clinical features depend on the species of Leishmania involved and the immune response of the host. Manifestations range from the localized cutaneous to the visceral form with potentially fatal outcomes. Many drugs are used in its treatment, but the only effective treatment is achieved with current pentavalent antimonials.">
            <meta name="dc.subject" content="Leishmaniasis, Leishmania, cutaneous-chondral, chicleros ulcer">
            <meta name="dc.creator" content="Torres-Guerrero, Edoardo">
            <meta name="dc.creator" content="Quintanilla-Cedillo, Marco Romano">
            <meta name="dc.creator" content="Ruiz-Esmenjaud, Julieta">
            <meta name="dc.creator" content="Arenas, Roberto">
            <meta name="dc.date" content="2017/05/26">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.11120.1">
            <meta name="dc.source" content="F1000Research 2017 6:750">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Leishmaniasis">
            <meta name="prism.keyword" content=" Leishmania">
            <meta name="prism.keyword" content=" cutaneous-chondral">
            <meta name="prism.keyword" content=" chicleros ulcer">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/05/26">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="750">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.11120.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-750">
            <meta name="citation_title" content="Leishmaniasis: a review">
            <meta name="citation_abstract" content="Leishmaniasis is caused by an intracellular parasite transmitted to humans by the bite of a sand fly. It is endemic in Asia, Africa, the Americas, and the Mediterranean region. Worldwide, 1.5 to 2 million new cases occur each year, 350 million are at risk of acquiring the disease, and leishmaniasis causes 70,000 deaths per year. Clinical features depend on the species of Leishmania involved and the immune response of the host. Manifestations range from the localized cutaneous to the visceral form with potentially fatal outcomes. Many drugs are used in its treatment, but the only effective treatment is achieved with current pentavalent antimonials.">
            <meta name="citation_description" content="Leishmaniasis is caused by an intracellular parasite transmitted to humans by the bite of a sand fly. It is endemic in Asia, Africa, the Americas, and the Mediterranean region. Worldwide, 1.5 to 2 million new cases occur each year, 350 million are at risk of acquiring the disease, and leishmaniasis causes 70,000 deaths per year. Clinical features depend on the species of Leishmania involved and the immune response of the host. Manifestations range from the localized cutaneous to the visceral form with potentially fatal outcomes. Many drugs are used in its treatment, but the only effective treatment is achieved with current pentavalent antimonials.">
            <meta name="citation_keywords" content="Leishmaniasis, Leishmania, cutaneous-chondral, chicleros ulcer">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Edoardo Torres-Guerrero">
            <meta name="citation_author_institution" content="Secci&oacute;n de Micolog&iacute;a, Hospital &ldquo;Manuel Gea Gonz&aacute;lez&rdquo; Secretar&iacute;a de Salud, Calz. de Tlalpan 4800, Ciudad de M&eacute;xico 14080, Mexico">
            <meta name="citation_author" content="Marco Romano Quintanilla-Cedillo">
            <meta name="citation_author_institution" content="Dermat&oacute;logo, Cl&iacute;nica Carranza, Chetumal, Quintana Roo, Mexico">
            <meta name="citation_author" content="Julieta Ruiz-Esmenjaud">
            <meta name="citation_author_institution" content="Secci&oacute;n de Micolog&iacute;a, Hospital &ldquo;Manuel Gea Gonz&aacute;lez&rdquo; Secretar&iacute;a de Salud, Calz. de Tlalpan 4800, Ciudad de M&eacute;xico 14080, Mexico">
            <meta name="citation_author" content="Roberto Arenas">
            <meta name="citation_author_institution" content="Secci&oacute;n de Micolog&iacute;a, Hospital &ldquo;Manuel Gea Gonz&aacute;lez&rdquo; Secretar&iacute;a de Salud, Calz. de Tlalpan 4800, Ciudad de M&eacute;xico 14080, Mexico">
            <meta name="citation_publication_date" content="2017/05/26">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="750">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.11120.1">
            <meta name="citation_firstpage" content="750">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-750/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-750.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=11996 /> <input type=hidden id=articleId name=articleId value=11120 /> <input type=hidden id=xmlUrl value="/articles/6-750/v1/xml"/> <input type=hidden id=xmlFileName value="-6-750-v1.xml"> <input type=hidden id=article_uuid value=484038af-bb9e-47e0-99a1-f63e2d01f75d /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Leishmaniasis: a review"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.11120.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.11120.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-750"
  },
  "headline": "Leishmaniasis: a review",
  "datePublished": "2017-05-26T12:32:32",
  "dateModified": "2017-05-26T12:32:32",
  "author": [
    {
      "@type": "Person",
      "name": "Edoardo Torres-Guerrero"
    },    {
      "@type": "Person",
      "name": "Marco Romano Quintanilla-Cedillo"
    },    {
      "@type": "Person",
      "name": "Julieta Ruiz-Esmenjaud"
    },    {
      "@type": "Person",
      "name": "Roberto Arenas"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Leishmaniasis is caused by an intracellular parasite transmitted to humans by the bite of a sand fly. It is endemic in Asia, Africa, the Americas, and the Mediterranean region. Worldwide, 1.5 to 2 million new cases occur each year, 350 million are at risk of acquiring the disease, and leishmaniasis causes 70,000 deaths per year. Clinical features depend on the species of Leishmania involved and the immune response of the host. Manifestations range from the localized cutaneous to the visceral form with potentially fatal outcomes. Many drugs are used in its treatment, but the only effective treatment is achieved with current pentavalent antimonials."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-750/v1",
            "name": "Leishmaniasis: a review"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Leishmaniasis: a review </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=11996 data-id=11120 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11120.1" data-recommended="" data-doi="10.12688/f1000research.11120.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-750/v1/pdf?article_uuid=484038af-bb9e-47e0-99a1-f63e2d01f75d" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-11120-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-11120-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-11120-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Torres-Guerrero E, Quintanilla-Cedillo MR, Ruiz-Esmenjaud J and Arenas R. Leishmaniasis: a review [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):750 (<a class=new-orange href="https://doi.org/10.12688/f1000research.11120.1" target=_blank>https://doi.org/10.12688/f1000research.11120.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-11120-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=11120 id=track-article-signin-11120 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11120?target=/articles/6-750/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=11996 /> <input name=articleId type=hidden value=11120 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Leishmaniasis: a review</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Edoardo Torres-Guerrero<a href="https://orcid.org/0000-0002-5026-2581" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-5026-2581</div><sup>1</sup>,&nbsp;</span><span class="">Marco Romano Quintanilla-Cedillo<sup>2</sup>,&nbsp;</span><span class="">Julieta Ruiz-Esmenjaud<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:rarenas98@hotmail.com" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Roberto Arenas</span></a><a href="https://orcid.org/0000-0003-2394-2730" target=_blank id=author-orcid-3><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-3><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-2394-2730</div><sup>1</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Edoardo Torres-Guerrero<a href="http://orcid.org/0000-0002-5026-2581" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-5026-2581</div><sup>1</sup>,&nbsp;</span><span class="">Marco Romano Quintanilla-Cedillo<sup>2</sup>,&nbsp;</span><span class="">Julieta Ruiz-Esmenjaud<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:rarenas98@hotmail.com" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Roberto Arenas</span></a><a href="http://orcid.org/0000-0003-2394-2730" target=_blank id=mauthor-orcid-3><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-3><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-2394-2730</div><sup>1</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 26 May 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.11120.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Secci&oacute;n de Micolog&iacute;a, Hospital &ldquo;Manuel Gea Gonz&aacute;lez&rdquo; Secretar&iacute;a de Salud, Calz. de Tlalpan 4800, Ciudad de M&eacute;xico 14080, Mexico<br/> <sup>2</sup> Dermat&oacute;logo, Cl&iacute;nica Carranza, Chetumal, Quintana Roo, Mexico<br/> <p> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=23076-23058></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=23075-23059></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Leishmaniasis is caused by an intracellular parasite transmitted to humans by the bite of a sand fly. It is endemic in Asia, Africa, the Americas, and the Mediterranean region. Worldwide, 1.5 to 2 million new cases occur each year, 350 million are at risk of acquiring the disease, and leishmaniasis causes 70,000 deaths per year. Clinical features depend on the species of <i>Leishmania </i>involved and the immune response of the host. Manifestations range from the localized cutaneous to the visceral form with potentially fatal outcomes. Many drugs are used in its treatment, but the only effective treatment is achieved with current pentavalent antimonials. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Leishmaniasis, Leishmania, cutaneous-chondral, chicleros ulcer </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Roberto Arenas (<a href="mailto:rarenas98@hotmail.com">rarenas98@hotmail.com</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Roberto Arenas </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> The authors declare that they have no competing interests. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp;  2017 Torres-Guerrero E <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Torres-Guerrero E, Quintanilla-Cedillo MR, Ruiz-Esmenjaud J and Arenas R. Leishmaniasis: a review [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):750 (<a href="https://doi.org/10.12688/f1000research.11120.1" target=_blank>https://doi.org/10.12688/f1000research.11120.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 26 May 2017, <b>6</b>(F1000 Faculty Rev):750 (<a href="https://doi.org/10.12688/f1000research.11120.1" target=_blank>https://doi.org/10.12688/f1000research.11120.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 26 May 2017, <b>6</b>(F1000 Faculty Rev):750 (<a href="https://doi.org/10.12688/f1000research.11120.1" target=_blank>https://doi.org/10.12688/f1000research.11120.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d22068e195>Introduction</h2><p class="" id=d22068e198>Leishmaniasis is a tropical and subtropical disease caused by an intracellular parasite transmitted to humans by the bite of a sand fly, mainly <i>Phlebotomus</i> and <i>Lutzomyia</i> (Europe, Northern Africa, the Middle East, Asia, and part of South America); exceptionally, transmission has also been reported as a laboratory accident<sup><a href="#ref-1">1</a></sup>. According to the World Health Organization (WHO), leishmaniasis is one of the seven most important tropical diseases and it represents a serious world health problem that presents a broad spectrum of clinical manifestations with a potentially fatal outcome<sup><a href="#ref-2">2</a>,<a href="#ref-3">3</a></sup>. It is found in all continents except Oceania<sup><a href="#ref-2">2</a>,<a href="#ref-4">4</a></sup> and is endemic in circumscribed geographic areas in Northeastern Africa, Southern Europe, the Middle East, Southeastern Mexico, and Central and South America.</p><p class="" id=d22068e225>The clinical features include a broad range of manifestations with different degrees of severity that depend on the species of <i>Leishmania</i> involved and the immune response of the host<sup><a href="#ref-3">3</a></sup>. In Mexico, the most characteristic form is the cutaneous-chondral form<sup><a href="#ref-1">1</a>,<a href="#ref-4">4</a></sup>, also called chicleros ulcer.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d22068e245>Epidemiology</h2><p class="" id=d22068e248>Leishmaniasis is a disease with a worldwide distribution; it is found in about 89 countries<sup><a href="#ref-4">4</a>,<a href="#ref-5">5</a></sup>. It is endemic in Asia, Africa, the Americas, and the Mediterranean region. In the American continent, it is mainly a jungle zoonosis (but it can be acquired in semi-desert or cold regions) transmitted by sand flies mainly of the genera <i>Phlebotomus</i> and <i>Lutzomyia</i>. It is found in many countries, from the southern United States to the northern provinces of Argentina (seroprevalence of 0.17% for cutaneous leishmaniasis [CL])<sup><a href="#ref-6">6</a></sup> with the exceptions of Chile, Uruguay, and El Salvador<sup><a href="#ref-4">4</a>,<a href="#ref-7">7</a>,<a href="#ref-8">8</a></sup>.</p><p class="" id=d22068e278>Between 12 and 15 million people in the world are infected, and 350 million are at risk of acquiring the disease. An estimated 1.5 to 2 million new cases occur each year, and it causes 70,000 deaths per year<sup><a href="#ref-4">4</a>,<a href="#ref-9">9</a></sup>.</p><p class="" id=d22068e288>In 2012, the WHO led an effort to report on the burden and distribution of leishmaniasis in 102 countries, areas, or territories worldwideto identify cases of CL and visceral leishmaniasis (VL)and the data until 2010 indicate that 90% of global cases of VL occurred in Bangladesh, Brazil, Ethiopia, India, South Sudan, and Sudan and that about 70% of CL cases occurred in Afghanistan, Algeria, Brazil, Colombia, Costa Rica, Ethiopia, Iran, Sudan, and the Syrian Arab Republic.</p><p class="" id=d22068e291>On the other hand, of 25 countries selected to study the burden of this disease, 13 have a high burden of VL (Bangladesh, China, Ethiopia, Georgia, India, Kenya, Nepal, Paraguay, Somalia, South Sudan, Spain, Sudan, and Uganda), 11 have a high burden of CL (Afghanistan, Algeria, Colombia, Iran, Morocco, Pakistan, Peru, Saudi Arabia, Syrian Arab Republic, Tunisia, and Turkey), and one (Brazil) has a high burden of both clinical forms<sup><a href="#ref-10">10</a></sup>. In Turkey, around 2,000 autochthonous cases of CL are reported each year.</p><p class="" id=d22068e299>Owing to the civil war in Syria, Turkey received around 3 million refugees, and they are located mainly at either camps or homes in the south or southeastern part of Turkey. An epidemiological study conducted in Turkey from 2009 to 2015 with 263 patients positive for leishmaniasis using real-time and semi-nested polymerase chain reactions (PCRs) revealed that 66.15% were Turkish, 33.46% were Syrian, and 0.38% were Afghani; the species detected were <i>Leishmania tropica</i> and <i>Leishmania infantum</i> (from Turkish and Syrian patients), demonstrating the effects of the war in that territory<sup><a href="#ref-11">11</a></sup>.</p><p class="" id=d22068e312>Khezzani and Bouchemal, in Algeria, reported 4,813 confirmed cases of CL in a period of 13 years: the disease affected all municipalities and all age groups<sup><a href="#ref-12">12</a></sup>. The most affected individuals were 10 to 19 years old (31.41%) and children less than 9 years old (25.70%). Most of the patients were males (65%).</p><p class="" id=d22068e319>In Iran, Holakouie-Naieni <i>et al</i>. identified the geographic and seasonal distribution of CL: there were 589,913 cutaneous cases, the annual incidence was approximately 30.9 per 100,000 and most cases occurred in the central regions of the country<sup><a href="#ref-13">13</a></sup>, and the highest prevalence rate (35.14%) of lesions occurred in autumn<sup><a href="#ref-14">14</a></sup>.</p><p class="" id=d22068e333>VL, also known as kala-azar, is a clinical form endemic in Bangladesh, India, and Nepal. More than 60% of all VL cases worldwide correspond to South Asia, with a predominance in rural areas. In this respect, in Nepal, approximately 5.7 million people are considered to be at risk and are confined mainly to the Terai region, which borders the VL-endemic districts of the Bihar state in India. Moreover, from 1980 to 2007, a total of 23,368 cases, including 311 deaths, were reported. According to the annual health report of the Department of Health Services in Nepal, the incidence of VL was 2.67 per 10,000 people at risk in 20062007<sup><a href="#ref-15">15</a></sup>.</p><p class="" id=d22068e340>In Latin America, it is estimated that around 60,000 new cases (including all types) occur each year. The disease is typical of environments with an altitude of 0 to 1,500 m above sea level, temperatures higher than 20C, and an annual rainfall of 1,500 to 3,000 mm. However, some cases known locally as Uta have been documented in the highlands of Peru, which are cold and humid places where the disease is transmitted by a small insect<sup><a href="#ref-16">16</a>,<a href="#ref-17">17</a></sup>.</p><p class="" id=d22068e350>More commonly, it affects men, and in Mexico the main risks are seen among farmers (gum tree harvesters, cocoa and banana farmers, among others), loggers, hunters, precious timber exploiters, military personnel, biologists, ornithologists, and those who practice ecological tourism; it affects the collectors of yerba mate (tea), rubber, banana, coffee, and coca in Peru and Brazil<sup><a href="#ref-1">1</a>,<a href="#ref-17">17</a>,<a href="#ref-18">18</a></sup>.</p><p class="" id=d22068e364>Women, the elderly, and children are also at risk of exposure in endemic zones. In Mexico, the disease has been known since the pre-Hispanic era<sup><a href="#ref-18">18</a></sup>, and all of the clinical forms of leishmaniasis have been reported<sup><a href="#ref-19">19</a></sup>. The most common presentations are the pure cutaneous and the cutaneous-chondral forms, which when affecting the ear cause the classic chicleros ulcer (gum tree harvesters ulcer). The main endemic area in this country is found in the Neotropical zone from the southeast (southern Veracruz, Tabasco, Oaxaca, Chiapas, Campeche, Quintana Roo, and part of Yucatn)<sup><a href="#ref-1">1</a>,<a href="#ref-2">2</a>,<a href="#ref-7">7</a>,<a href="#ref-18">18</a>,<a href="#ref-20">20</a></sup> (<a href="#f1">Figure 1</a>). In this country, an annual incidence of 5.08 cases per 100,000 population has been observed in the Yucatn Peninsula<sup><a href="#ref-21">21</a>,<a href="#ref-22">22</a></sup>. Serological studies carried out in Becanchn (southern state of Yucatn) have documented specific antibodies in 17% of the general population. Also, in Tabasco, an incidence and prevalence rate of 2.35 and 9.41 per 100,000 population, respectively, have been observed; therefore, it is considered a high-endemic zone<sup><a href="#ref-18">18</a></sup>. These rates are explained because farmers work only 10 km from the site in which the greatest quantity of rodents reservoirs and transmission vectors are found<sup><a href="#ref-23">23</a></sup>. Positive serology is observed in 20.42% of military personnel working in this zone<sup><a href="#ref-24">24</a></sup>. The two main vectors of this disease in the Yucatn Peninsula are <i>Lutzomyia olmeca</i> and <i>Lutzomyia cruciate</i><sup><a href="#ref-23">23</a>,<a href="#ref-25">25</a></sup>. In Campeche and Yucatn (Mexico), <i>Leishmania mexicana</i> is the main causative agent; <i>Leishmania braziliensis</i> predominates in Belize and Guatemala, where cases of <i>L. mexicana</i> have also been reported.</p><div class="fig panel clearfix"><a name=f1 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/11996/b486475c-69af-4eae-aa3b-94673fb0fd60_figure1.gif"><img alt="b486475c-69af-4eae-aa3b-94673fb0fd60_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/11996/b486475c-69af-4eae-aa3b-94673fb0fd60_figure1.gif"></a><div class=caption><h3>Figure 1. Rainforests where chewing gum workers and farmers extract sap from <i>Manilkara zapota</i> trees (chewing gum tree).</h3></div></div><p class="" id=d22068e453>In an epidemiological study in Matto Grosso (Brazil), Thies <i>et al</i>. showed that the frequency and diversity of sand flies were higher in rural areas with no deforestation (areas of permanent preservation [96.85%]) than in urban areas<sup><a href="#ref-26">26</a></sup>. <i>Lutzomyia dasypodogeton</i> was the most frequent species in areas of preservation, <i>Lutzomyia antunesi</i> was more frequent in neighborhoods with forest fragments and semi-urban areas, and <i>Lutzomyia aragaoi</i> was the most frequent species in completely urbanized neighborhoods; 87.92% of frequency and diversity of sand flies was observed in the rainy season versus 12.08% in the dry season.</p><p class="" id=d22068e472>In a descriptive study conducted by Vita <i>et al</i>., supported by data from the Brazilian Information System of Notifiable Diseases (SINAN) and the Brazilian Institute of Geography and Statistics (IBGE), 1,470 cases of CL were analyzed; 87.89% were of the cutaneous clinical form, and there were higher incidences in the white ethnic group (49.72%) and in the 20- to 39-year-old age group (32.44%)<sup><a href="#ref-27">27</a></sup>. These researchers concluded that there was a decrease in the number of cases based on a coefficient of detection from 1.44 per 100,000 inhabitants in 2004 to 0.20 per 100,000 in 2013.</p><p class="" id=d22068e482>In an epidemiological and historic study in Palestine, Al-Jawabreh <i>et al</i>. identified <i>Leishmania</i> species by using amplification products from a PCR-internal transcribed spacer 1 (PCR-ITS1) followed by restriction fragment length polymorphism (RFLP) analysis using Hae III and showed that the case numbers peaked in 1995, 2001, 2004, and 2012<sup><a href="#ref-28">28</a></sup>. Statistically significant clusters of cases caused by <i>Leishmania major</i> were restricted to the Jericho District, and those caused by <i>L. tropica</i> were located in the districts of Jericho, Bethlehem, Nablus, and Tubas.</p><p class="" id=d22068e501>In an epidemiological study in Afghanistan, Fakhar <i>et al</i>. confirmed 3,861 cases of CL in a period of 1 year, and the predominant species of all molecularly identified samples using ITS1 PCR-RFLP analysis was <i>L. tropica</i> (98%)<sup><a href="#ref-29">29</a></sup>.</p><p class="" id=d22068e515>CL is found in Southern Europe, Asia (the Middle East, Afghanistan, and Pakistan), Africa, and Latin America. On the other hand, the cases of cutaneous disseminated leishmaniasis have been described in the northeast of Mexico and in states neighboring the southern United States and in the state of Texas<sup><a href="#ref-7">7</a>,<a href="#ref-20">20</a></sup>.</p><p class="" id=d22068e525>Muco-cutaneous leishmaniasis is found in Latin America and less frequently in Africa (Ethiopia and Sudan). VL, or kala-azar, is found in Northern and Eastern Africa and in Northern Asia (India, Pakistan, Bangladesh, Nepal, and China), in Southern Europe, and in Latin America<sup><a href="#ref-8">8</a></sup>. Bangladesh, Bhutan, India, and Nepal represented more than 73% of the global burden of VL in 2012, and the prevalence of confirmed postkala-azar dermal leishmaniasis ranged between 4.4 and 4.8 per 10,000 population in Bangladesh and India<sup><a href="#ref-30">30</a></sup>.</p><p class="" id=d22068e536>Transmission of this disease is low in deforested areas, and the only isolated species in those habitats has been <i>Lutzomyia deleoni</i>, which is not an anthropophilic species<sup><a href="#ref-25">25</a></sup>. Nevertheless, since 1960, Forattini has emphasized the potential capability of vectors to adapt to suburban and urban environments<sup><a href="#ref-7">7</a></sup>. Important contributors for the spread of leishmaniasis include environmental factors such as alterations in temperature and water storage, irrigation patterns, deforestation, climate changes, immunosuppression by HIV, organ transplant or immunotherapy, development of drug resistance, increased traveling to endemic regions, dog importation, wars, natural disasters, and communities with poor socioeconomic status<sup><a href="#ref-31">31</a></sup>.</p><p class="" id=d22068e554>Despite its great epidemiological importance, leishmaniasis is considered by the WHO to be a disease that has been neglected by different public and private organizations financing health improvement and research<sup><a href="#ref-1">1</a>,<a href="#ref-4">4</a></sup>.</p><p class="" id=d22068e564>As part of the adaptation phenomenon of vectors to semi-urban and urban environments, domestic animals play a role as new opportunistic hosts<sup><a href="#ref-4">4</a></sup>. A hypothesis that would explain the new epidemiological dynamics is the progressive destruction of the vectors natural habitat by humans, natural disasters, and global warming. The populations at risk are defined by patterns of human travel related to tourism and by populations displaced by wars, economic crises, and natural disasters<sup><a href="#ref-4">4</a></sup>. In this regard, the case of Afghanistan is particularly telling. In its capital, Kabul, there were practically no reported cases of leishmaniasis before 1990; however, by 2003, 25,000 cases were documented and treated. Newer data have indicated 67,500 new cases per year<sup><a href="#ref-4">4</a>,<a href="#ref-8">8</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d22068e585>Etiopathogenesis</h2><p class="" id=d22068e588>The putative vectors of the different species and subspecies of protozoa of the <i>Leishmania</i> genus are dipterans of the genus <i>Lutzomyia</i> in the New World and <i>Phlebotomus</i> in the old continent belonging to the subfamily Phlebotominae. The taxonomy of these vectors is as follows:</p><p class="" id=d22068e600>Kingdom&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Animal</p><p class="" id=d22068e603>Phylum&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Arthropoda</p><p class="" id=d22068e606>Subphylum&nbsp;&nbsp;&nbsp;Euarthropoda</p><p class="" id=d22068e610>Superclass&nbsp;&nbsp;&nbsp;&nbsp;Antenata</p><p class="" id=d22068e613>Class&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Insecta/Hexapoda</p><p class="" id=d22068e616>Order&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diptera</p><p class="" id=d22068e619>Suborder&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nematocera (considered the most ancient members, dating to the Jurassic period)</p><p class="" id=d22068e622>Family&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Psychodidae</p><p class="" id=d22068e625>Subfamily&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Phlebotominae</p><p class="" id=d22068e629>Genus&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Old World: <i>Phlebotomus/Sergentomyia</i> </p><p class="" id=d22068e635>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;New World: <i>Lutzomyia</i> (with six subgenera: <i>Lutzomyia</i>, <i>Dampomyia</i>, <i>Pintomyia</i>, <i>Nyssomyia</i>, <i>Psychodopygus</i>, and <i>Peruensis/Brumptomyia/Warileya/Psychodopygus</i>)</p><p class="" id=d22068e660>Species&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<i>Olmeca</i></p><p class="" id=d22068e665>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<i>Flaviscutellata</i></p><p class="" id=d22068e670>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<i>Trapidoi</i></p><p class="" id=d22068e675>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<i>Diabolica</i></p><p class="" id=d22068e681>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<i>Longipalpis</i> </p><p class="" id=d22068e687>The genus <i>Lutzomyia</i> includes 90% of the pathogenic species, most of which infect humans. <i>Lutzomyia</i> is present in the tropics of the New World. They display a dorsal hump and wings with a lanceolate oval shape. Only females nourish from blood, usually from mammals but sometimes also from inferior terrestrial vertebrates. Usually they nourish at night; during the day, they hide in dark, humid places. <i>Lutzomyia</i> absorb sugars that may have an important role in the development of <i>Leishmania</i> in the vector species<sup><a href="#ref-7">7</a></sup>.</p><p class="" id=d22068e706>Laison and Shaw proposed a classification of leishmaniasis on the basis of their pattern of development in the bowel of the sand fly, which not only assumes evolution of the parasites but also allows their classification into groups such as suprapillary, peripillary, and hypopillary. In the hypopillary group, infection is limited to the hindgut (that is, pylorus ileum and rectum). The reservoirs hosts are limited to reptiles from the Old World: <i>Leishmania agamae</i> and <i>Leishmania ceramodactyli</i>. The peripillary group requires mandatory development of the parasite in the hindgut but migrates to the midgut and foregut. The reservoir hosts are reptiles in the Old World (<i>Leishmania adleri</i> and <i>Leishmania tarentolae</i>) and mammals in the New World (<i>L. braziliensis</i> complex). In the suprapillary group, development does not occur in the hindgut, and the parasites are restricted to the midgut and foregut. The host reservoirs are mammals in the Old as well as in the New World (species: <i>tropica</i>, <i>major</i>, <i>donovani</i>, <i>mexicana</i>, and <i>hertigi</i>). Therefore, those parasites are grouped into two subgenera: <i>Leishmania</i>, which includes parasites that develop in the midgut and foregut, and <i>Viannia</i>, which develops in the <i>Phlebotomus</i> foregut, midgut, and hindgut.</p><p class="" id=d22068e750>The subgenus <i>Viannia</i> (Laison and Shaw, 1987) includes the following: <i>L. braziliensis</i>, which is the most frequent causative agent of cutaneous and muco-cutaneous clinical forms; <i>Leishmania guyanensis</i>, whose geographical localization corresponds to the north of the Amazon River, the Guianas, Venezuela, and Peru and which is usually the cause of multiple cutaneous lesions; <i>Leishmania lainsoni</i>, which is limited almost exclusively to the Brazilian Amazon; <i>Leishmania shawi</i>, which is found in the Brazilian state of Par; <i>Leishmania naiffi</i>, which is distributed in Par and Amazonas (Brazil) and in the French Guiana and is responsible for the cutaneous form of the disease; <i>Leishmania peruviana</i>, which is found mostly in the Peruvian Andes and causes the CL form known locally as Uta; <i>Leishmania panamensis</i>, which is the responsible causative agent of the disease in Panama, Costa Rica, Colombia, Ecuador, and Honduras; and <i>Leishmania colombiensis</i>, which is found in Colombia, Panama, and Venezuela and has been seen in sporadic human cases.</p><p class="" id=d22068e781>The species of subgenus <i>Leishmania</i> (Saf Janova, 1982) includes the following: <i>Leishmania amazonensis</i>, which is responsible for the anergic diffuse cutaneous form and the cutaneous forms with disseminated lesions; <i>Leishmania chagasi</i>, which causes visceral American leishmaniasis and has a wide distribution in Latin America, extending from Mexico to Argentina; <i>L. mexicana</i>, which is observed in Mexico, Colombia, the Caribbean Sea region, and Ecuador and produces muco-cutaneous leishmaniasis (Espundia) and the classic cutaneous form known as chicleros ulcer (gum tree harvesters ulcer); <i>Leishmania pifanoi</i>, which is the causal agent of muco-cutaneous leishmaniasis in Venezuela; <i>Leishmania venezuelensis</i>, which is observed in the Venezuelan Andes; <i>Leishmania donovani</i>, which is responsible for VL in the Old World; <i>L. infantum</i>, which causes VL and CL in infants; <i>L. tropica</i>, which is the causal agent of CL; and <i>Leishmania aethiopica</i>, which is the causal agent of CL and muco-cutaneous leishmaniasis<sup><a href="#ref-32">32</a></sup>.</p><p class="" id=d22068e819>The duration of the life cycle in the vector varies from 4 to 18 days, depending on the species of <i>Leishmania</i>; it can be extended at low temperatures or shortened at high temperatures<sup><a href="#ref-7">7</a></sup>.</p><p class="" id=d22068e830>In Mexico, some rodent species have been identified as reservoirs for the parasites. For a species to be considered a reservoir, it must fulfill two criteria: (1) it must carry enough parasites to make it an effective vector at the moment of feeding and (2) in these species the infection must be relatively non-pathogenic or asymptomatic so as not to affect the survival of the reservoir<sup><a href="#ref-22">22</a></sup>. In these mammals, the skin and the blood provide adequate environments for the parasite to reproduce.</p><p class="" id=d22068e837>Laboratory studies from Ethiopia suggest that an <i>L. donovani</i> parasite load of 20,000 per mL of blood in the host is required to infect the sand fly species, such as <i>Phlebotomus orientalis</i><sup><a href="#ref-30">30</a></sup>.</p><p class="" id=d22068e849>Generally, more than half of reservoirs remain asymptomatic<sup><a href="#ref-22">22</a>,<a href="#ref-33">33</a></sup>. It is possible that dogs play some role in maintaining endemic peri-urban areas; in the border strip of Mexico and Belize and Guatemala, when workers dogs keep company with their masters in the woods, sometimes they develop ulcers that clinically resemble the lesions of leishmaniasis<sup><a href="#ref-17">17</a></sup>.</p><p class="" id=d22068e863>Human-to-human transmission (mediated by vectors without any other living species) has been well documented in some endemic areas; this means that a sand fly bites the human patient and then infects another human in an anthropozoonotic cycle<sup><a href="#ref-3">3</a>,<a href="#ref-4">4</a></sup>.</p><p class="" id=d22068e873>Moreover, the demonstration of parasite in the blood of domestic animals using molecular tools such as PCR has suggested that domestic animals could serve as an alternate reservoir for an infection in India. Domestic animals like pets or cattle could increase transmission pressure by virtue of being an untreated reservoir for the parasite, and their proximity to human owners may also increase the transmission ratio because of increased availability of blood meals for the sand fly as well as organic manure for breeding of larvae and resting. In mixed dwellings where cattle sheds are attached to the house, bovine origin represented 66% of the blood meals of the sand fly whereas human blood represented 19%; however, even though domestic animals are seen to be infected, there is not enough evidence of their role in anthroponotic transmission in India and the Indian subcontinent<sup><a href="#ref-30">30</a></sup>. Such a biological cycle has never been documented in the Yucatn Peninsula<sup><a href="#ref-3">3</a>,<a href="#ref-4">4</a></sup>. Factors that affect the occurrence of disease include the agent (species of <i>Leishmania</i>), the host (genetic susceptibility, degree of immunocompetence, poor nutrition, and other underlying diseases), and environment<sup><a href="#ref-4">4</a></sup>.</p><p class="" id=d22068e894>Hypotheses that explain these variations include (a) differences in the virulence of the parasites, (b) differences in the cutaneous permeability, (c) individual variations of genetic susceptibility of the host, and (d) variations in the attraction of the <i>Phlebotomus</i> toward different individuals<sup><a href="#ref-3">3</a>,<a href="#ref-4">4</a></sup>.</p><p class="" id=d22068e908>Parasite transmission from the sand fly to the host depends on how infective the host is, how infective the sand fly is with a single bite, the average rate of biting, and the number of sand flies present. The biting rate was calculated as 0.25 per daythe inverse of the feeding interval (4 days)and the latency period in the sand fly was 5 days<sup><a href="#ref-30">30</a></sup>.</p><p class="" id=d22068e915>When a human enters the jungle and is bitten by the infected <i>Phlebotomus</i>, the biological cycle, which is represented by the equation wild animal reservoir  <i>Phlebotomus</i>-infected female  wild healthy animal, is broken, converting it into wild animal reservoir  <i>Phlebotomus</i>-infected female  healthy human<sup><a href="#ref-32">32</a></sup>.</p><p class="" id=d22068e931>The causal agent is an obligatory unicellular protozoan of the family <i>Trypanosomatidae</i>, suborder <i>Trypanosomatina</i>, and the genus <i>Leishmania.</i> Two stages in the life cycle have been defined: a promastigote (flagellated) that measures 12 to 20 m is found in arthropods (diptera), which represent the vector that is infected while nourishing from the blood of the vertebrate host. It remains in the gut of the diptera where, within 4 to 25 days, it shows a second stage as an amastigote (non-flagellated); this is an obligatory intracellular parasite that measures from 2.5 to 3.5 m and is localized to the phagocytic cells of the host. The infected female <i>Phlebotomus</i> (which is hematophagous), when biting the infected animal, absorbs the amastigote forms from the blood of the reservoir. In the insects gut, the parasite begins a process of transformation and the amastigotes change to procyclic promastigotes and then to metacyclic promastigotes; the latter have infectious capacity, and, upon biting a healthy animal, the vector inoculates it by regurgitating such promastigotes<sup><a href="#ref-1">1</a>,<a href="#ref-4">4</a>,<a href="#ref-8">8</a>,<a href="#ref-32">32</a></sup>.</p><p class="" id=d22068e959>When the parasite is deposited by regurgitation in the host tegument, it is phagocytized by local macrophages and epidermal Langerhans cells without the involvement of circulating monocytic cells, so this is a local event only in the skin, constituting localized CL (LCL).</p><p class="" id=d22068e962>The host machinery that mediates amastigote uptake is poorly understood; however, it is known that, in the human host, amastigotes bind Fc receptors and enter macrophages primarily through immunoglobulin-mediated phagocytosis. Wetzel <i>et al</i>. demonstrated that a tyrosine kinase non-receptor known as Abl2 facilitates <i>L. amazonensis</i> amastigote uptake by macrophages<sup><a href="#ref-34">34</a></sup>. Once inside the phagolysosomes, promastigotes differentiate into amastigotes and proliferate extensively by binary fission, evading the immune response. The biological cycle described is performed in 53 to 100 days<sup><a href="#ref-1">1</a>,<a href="#ref-8">8</a>,<a href="#ref-9">9</a></sup>. Pathogen species for humans are classified according to their molecular biology, and in America the predominant complexes are <i>L. mexicana</i> and <i>L. braziliensis</i>. In the Old World, the disease is caused by <i>L. tropica</i>, <i>L. major</i>, <i>L. aethiopica</i>, <i>L. donovani</i>, and <i>L. infantum</i>. According to the type of immune response elicited, the disease can be localized; it can have a tendency to be spontaneously healing or generalized and progressive<sup><a href="#ref-35">35</a></sup>.</p><p class="" id=d22068e1012>Different factors that determine the parasites virulence have been identified experimentally and may help to understand the mechanisms of evasion of the immune response by the parasite. These can be classified into three main categories: (1) invasive and evasive determinants, such as lipophosphoglycans (not found in <i>L. mexicana</i>), leishmanolysin, and proteasomes; (2) pathoantigenic determinants such as histone chaperones or proteasomes; and (3) protective determinants, which are still being identified. On the other hand, it has been recognized that different components in the saliva of the <i>Phlebotomus</i> determine the local reaction after the bite.</p><p class="" id=d22068e1022>The immunological basis of these findings is not completely understood; however, it is known that an adaptive change in the immune response occurs with a shifting from Th1 to Th2 with increments in the production of interleukin-4 (IL-4) and IL-6 or rather through inhibition of tumor necrosis factor alpha (TNF), interferon gamma (IFN), IL-12, and the production of nitric oxide<sup><a href="#ref-36">36</a></sup>.</p><p class="" id=d22068e1029>The immune response can vary depending on each clinical form. In the LCL forms, humoral immunity is not triggered; in the muco-cutaneous form, specific IgG antibodies can be detected; and in the diffuse cutaneous form, high levels of IgA are occasionally detected.<b></b>Production of IL-4 in the first few weeks after disease onset has been observed; faster resolution of the lesions is mediated by the production of IFN by CD8 T lymphocytes<sup><a href="#ref-35">35</a></sup>. It was also observed that the immune response of resistance to infections caused by <i>L. major</i> is mediated mainly by a Th1 response with the activation of macrophages, in which the production of IFN predominates and prevents recrudescence and the development of chronic clinical forms.</p><p class="" id=d22068e1041>On the other hand, progression of the disease has been associated with a Th2 type response and greater production of IL-4, IL-5, transforming growth factor beta (TGF), and IL-10. Similar studies have found an increment in the production of IL-1, IL-6, IL-10, TGF, IFN, and TNF during the early lesions of LCL, but in the chronic lesions cytokines are decreased<sup><a href="#ref-37">37</a><a href="#ref-39">39</a></sup>. In cases of VL, abnormal patterns of resistance, which were related to class II molecules of the major histocompatibility complex, have been identified. In cases of leishmaniasis caused by <i>L. major</i>, it has been observed that natural killer cells play a role in the initiation of differentiation of T CD4 lymphocytes and in the control of the initial response<sup><a href="#ref-35">35</a></sup>. During VL, intracellular parasites are managed via the activation of Th1-associated inflammation. IL-10, and eventually programmed death 1-mediated T-cell exhaustion, diminishes pathology caused by inflammation. It is not known which cell types are responsible for initiating T cellproduced IL-10 during VL; however, the population of IgD (hi) B cells was found to grow threefold during the progression of VL<sup><a href="#ref-40">40</a></sup>.</p><p class="" id=d22068e1062>In both forms, there is an association between CD4<sup>+</sup> Th1 lymphocytes with resistance and Th2 with susceptibility. Nevertheless, it is clear that CD4 as well as CD8 lymphocytes are activated and required to control the disease<sup><a href="#ref-35">35</a></sup>.</p><p class="" id=d22068e1072>Because of these observations, it can be said that the spectral behavior of leishmaniasis is similar to that of leprosy in such a way that LCL represents the hyperergic pole in which patients have an intense cellular response and at the other end of the spectrum is diffuse CL with a progressive course and usually a fatal outcome.</p><p class="" id=d22068e1075>These two ends of the spectrum yield a positive and negative response, respectively, to the leishmanin skin test (intradermal Montenegros reaction). The muco-cutaneous form is a variant of the hyperergic spectrum always produced by <i>L. braziliensis</i> and by definition is not part of the spectrum of the cutaneous forms<sup><a href="#ref-1">1</a>,<a href="#ref-4">4</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d22068e1091>Classification and clinical picture</h2><p class="" id=d22068e1094>The clinical features vary depending on the parasites characteristics and on the genetic aspects of the host that determine the effectiveness of the immune response. According to the clinical manifestations, it can be divided into (1) cutaneous (localized and disseminated), (2) muco-cutaneous, and (3) visceral or kala-azar<sup><a href="#ref-2">2</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d22068e1104>Localized cutaneous leishmaniasis</h2><p class="" id=d22068e1107>Pure CL was first described in the Old World by Lewis and Cunningham in 1876. It is caused by <i>L. tropica</i><sup><a href="#ref-17">17</a></sup>. In the Mexican Southwest and at its border with Guatemala, the causal agent is <i>L. mexicana</i><sup><a href="#ref-2">2</a></sup>. It occurs in areas of the body exposed to insect bites; in decreasing order of frequency, the most involved regions are the ears (areas usually involved are the helix and anti-helix), nose, upper lip, cheeks, legs, hands and forearms, and ankles<sup><a href="#ref-17">17</a></sup>. It is striking that in Guatemala the most affected sites are the upper limbs (up to 43% of cases)<sup><a href="#ref-3">3</a></sup>. The incubation period is from 1 to 4 weeks<sup><a href="#ref-2">2</a></sup> but can last for up to several years<sup><a href="#ref-1">1</a></sup>. Patients may refer to previous travel to endemic zones<sup><a href="#ref-2">2</a></sup>.</p><p class="" id=d22068e1143>It is characterized by a local increase in temperature and swelling. An erythematous asymptomatic papule appears at the site of the bite, although pruritus may be present. The size ranges from 1 to 10 mm in diameter. After 2 days, it turns into a vesicle and later into a pustule, and when it breaks, either spontaneously or by trauma due to scratching, it results in a rounded ulcer with nodular or thick borders with sharp and peaked edges (<a href="#f2">Figure 2</a>). Such ulcers can last from 35 months to 1520 years. The bottom of the ulcer shows granulation tissue that bleeds when rubbing and a pink periphery and sometimes is covered by a whitish pseudo-membrane (<a href="#f3">Figure 3</a>). In some cases, abundant secretion forms an adherent crust<sup><a href="#ref-17">17</a></sup>. The lesion is not painful if it is not secondarily infected. Ulcers may be solitary or multiple; autoinoculation has been observed with the infection at sites distant to the previous mosquito bite (as in the forearms) by prolonged contact with ulcerated areas<sup><a href="#ref-1">1</a>,<a href="#ref-41">41</a></sup>. The clinical picture is usually afebrile with regional adenopathy<sup><a href="#ref-2">2</a>,<a href="#ref-17">17</a></sup>.</p><div class="fig panel clearfix"><a name=f2 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/11996/b486475c-69af-4eae-aa3b-94673fb0fd60_figure2.gif"><img alt="b486475c-69af-4eae-aa3b-94673fb0fd60_figure2.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/11996/b486475c-69af-4eae-aa3b-94673fb0fd60_figure2.gif"></a><div class=caption><h3>Figure 2. Early ulcer on the forearm with meliceric crust.</h3></div></div><div class="fig panel clearfix"><a name=f3 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/11996/b486475c-69af-4eae-aa3b-94673fb0fd60_figure3.gif"><img alt="b486475c-69af-4eae-aa3b-94673fb0fd60_figure3.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/11996/b486475c-69af-4eae-aa3b-94673fb0fd60_figure3.gif"></a><div class=caption><h3>Figure 3. Ulcer on the upper limb with crusts and raised borders.</h3></div></div><p class="" id=d22068e1199>On rare occasions, the initial lesion may not ulcerate and develop vegetating appearance<sup><a href="#ref-12">12</a>,<a href="#ref-28">28</a></sup>. LCL can heal spontaneously in 39 months in the case of <i>L. mexicana</i>, 26 months in the case of <i>L. major</i>, and 615 months if the agent is <i>L. braziliensis</i>, <i>L. tropica</i>, or <i>L. panamensis</i><sup><a href="#ref-4">4</a>,<a href="#ref-42">42</a>,<a href="#ref-43">43</a></sup>.</p><p class="" id=d22068e1234>Spontaneous healing in up to 4 years, in which healing progresses from the periphery to the center of the lesion, has been described<sup><a href="#ref-17">17</a></sup>. Spontaneous healing leaves a depressed plaque with uneven pigmentation and telangiectasia, or retractile scars with hypopigmented center and hyperpigmented periphery, as well as local deformity due to large tissue destruction (<a href="#f4">Figure 4</a>). When the ear is affected (chicleros or gum tree harvesters ulcer), it results in mutilations in the form of notches, or clefts<sup><a href="#ref-1">1</a>,<a href="#ref-17">17</a>,<a href="#ref-41">41</a></sup> (<a href="#f5">Figure 5</a> and <a href="#f6">Figure 6</a>).</p><div class="fig panel clearfix"><a name=f4 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/11996/b486475c-69af-4eae-aa3b-94673fb0fd60_figure4.gif"><img alt="b486475c-69af-4eae-aa3b-94673fb0fd60_figure4.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/11996/b486475c-69af-4eae-aa3b-94673fb0fd60_figure4.gif"></a><div class=caption><h3>Figure 4. Atrophic scar on forearm.</h3></div></div><div class="fig panel clearfix"><a name=f5 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/11996/b486475c-69af-4eae-aa3b-94673fb0fd60_figure5.gif"><img alt="b486475c-69af-4eae-aa3b-94673fb0fd60_figure5.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/11996/b486475c-69af-4eae-aa3b-94673fb0fd60_figure5.gif"></a><div class=caption><h3>Figure 5. Atrophic stage of chicleros ulcer with deforming scarring of the ear.</h3></div></div><div class="fig panel clearfix"><a name=f6 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/11996/b486475c-69af-4eae-aa3b-94673fb0fd60_figure6.gif"><img alt="b486475c-69af-4eae-aa3b-94673fb0fd60_figure6.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/11996/b486475c-69af-4eae-aa3b-94673fb0fd60_figure6.gif"></a><div class=caption><h3>Figure 6. Chicleros ulcer with bleeding bed and periphery covered by fibrin.</h3></div></div><p class="" id=d22068e1302>Around 33% of patients can relapse, or the scarring lesion may reopen, presenting with features similar to those of the original episode; recurring manifestations can be mild or more severe than those observed at the initial episode<sup><a href="#ref-1">1</a>,<a href="#ref-17">17</a></sup>, called <i>Leishmania recidivans</i><sup><a href="#ref-4">4</a></sup>. There is an abortive form in which the lesion is a regressive papule<sup><a href="#ref-44">44</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d22068e1326>Diffuse cutaneous leishmaniasis</h2><p class="" id=d22068e1329>This form is characterized by anergy (that is, lack of cellular immune response to parasite antigens). This allows dissemination through tissue, lymph, and blood pathways, developing lesions in most of the skin, except in the scalp, and sometimes with involvement of mucous membranes. It is observed in Central America, Amazonian Brazil, Venezuela, Ethiopia, and Kenya; is caused by the <i>L. mexicana</i> complex (<i>L. amazonensis</i>, <i>L. braziliensis</i> and <i>L. pifanoi</i>); and predominates in exposed areas (for example, the ears (pinna), cheeks, and extremities). It usually starts with hard erythematous nodules and reddish-brown infiltrative smooth or verrucous plaques. The latter may or may not ulcerate and are present first on the face and afterwards progressively affect the extremities, buttocks, and mucous membranes and in some cases can involve the entire skin surface (<a href="#f7">Figure 7</a>). Lymphedema, lymphadenopathy, poor general condition, and fever may be observed. When the mucosae such as the oropharynx and nasopharynx are involved, painful nodules may lead to airway obstruction. This clinical form is very difficult to treat, there is no spontaneous resolution, and a long evolution of up to 20 years has been observed<sup><a href="#ref-1">1</a>,<a href="#ref-4">4</a>,<a href="#ref-9">9</a></sup>.</p><div class="fig panel clearfix"><a name=f7 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/11996/b486475c-69af-4eae-aa3b-94673fb0fd60_figure7.gif"><img alt="b486475c-69af-4eae-aa3b-94673fb0fd60_figure7.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/11996/b486475c-69af-4eae-aa3b-94673fb0fd60_figure7.gif"></a><div class=caption><h3>Figure 7. Diffuse cutaneous leishmaniasis (anergic clinical form).</h3></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d22068e1375>Muco-cutaneous leishmaniasis, cutaneous-mucosal, American cutaneous, or Espundia</h2><p class="" id=d22068e1378>In South America and in endemic areas, it has been noted that in 1 to 10% of patients the LCL form evolves into muco-cutaneous leishmaniasis after 5 years of having healed. Cases from Bolivia, Brazil, and Peru represent 90% of this variant. The causal species of this clinical form belong to the complex <i>L. braziliensis</i>, which includes <i>L. braziliensis</i>, <i>L. guyanensis</i>, and <i>L. panamensis</i>. It causes invasion and destruction of the nasopharyngeal mucosa<sup><a href="#ref-45">45</a></sup> (<a href="#f8">Figure 8</a>). Invasion occurs slowly, sometimes causing no initial disturbance, thus allowing the mucosal injury to go unnoticed; on some occasions, it causes only mild local pruritus and swelling<sup><a href="#ref-4">4</a>,<a href="#ref-9">9</a>,<a href="#ref-17">17</a>,<a href="#ref-42">42</a>,<a href="#ref-46">46</a></sup>. In Panama, the Bejucos ulcer affecting young individuals is caused by <i>L. panamensis</i>.</p><div class="fig panel clearfix"><a name=f8 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/11996/b486475c-69af-4eae-aa3b-94673fb0fd60_figure8.gif"><img alt="b486475c-69af-4eae-aa3b-94673fb0fd60_figure8.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/11996/b486475c-69af-4eae-aa3b-94673fb0fd60_figure8.gif"></a><div class=caption><h3>Figure 8. Muco-cutaneous leishmaniasis (Espundia).</h3></div></div><p class="" id=d22068e1434>Usually, lesions start in the nasal mucosa and spread to the oral and pharynx mucosa, the larynx, and the skin of the nose and lips<sup><a href="#ref-1">1</a></sup>. Lesions of the oral mucosa usually produce symptoms that range from simple discomfort and mild pain or odynophagia to cachexia in extreme cases; the latter is observed only in cases in which the lesion involves the totality of the pharynx, larynx (with hoarseness), and esophagus (with dysphagia). Early in the disease, there is infiltration of the mucosa with superficial ulcerations; later on, when the ulcers are well developed, their borders have a necrotic appearance and are torn and detached. The uvula, pillars of the palate roof, and tonsils can be destroyed. Owing to superimposed infections, the regional lymph nodes can become infarcted and become painful. When the infection is in the nasal cavity, atrophy of the nasal turbinates and destruction of the cartilaginous septum with foul smell can occur and in extreme cases can cause death<sup><a href="#ref-4">4</a>,<a href="#ref-17">17</a>,<a href="#ref-46">46</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d22068e1454>Visceral leishmaniasis, or kala-azar (black fever)</h2><p class="" id=d22068e1457>The febrile infectious illness known as kala-azar (black fever) spreads over a large part of south and east Asia (mainly in India and China), a large part of Africa, the Mediterranean (affecting children and adults), and South America (where children are affected). It is caused by <i>L. donovani</i> (India and Eastern Africa), <i>L. infantum</i> (Mediterranean area), and <i>L. chagasi</i>, <i>L. amazonensis</i>, and <i>L. tropica</i> in South America<sup><a href="#ref-47">47</a>,<a href="#ref-48">48</a></sup>. The incubation period is from 3 to 8 months. The at-risk population includes preschool children and immunocompromised and undernourished individuals.</p><p class="" id=d22068e1483>Recently, this type of leishmaniasis has been seen with increasing frequency in patients who have AIDS or who are intravenous drug users or both, suggesting a potential transmission mechanism through contaminated syringes<sup><a href="#ref-1">1</a></sup>. Lesions in the reticuloendothelial system may follow a subclinical course (the minority of cases), or patients may be oligosymptomatic or frankly symptomatic. It is manifested by lymphadenopathy, hepatomegaly, splenomegaly, pallor, anemia, leukopenia, thrombocytopenia, fever, night sweats, weakness, anorexia, asthenia, cutaneous pigmentation, and weight loss, which can progress rapidly in weeks or months. In addition, affected children present characteristic chronic diarrhea and growth retardation.</p><p class="" id=d22068e1490>Typical laboratory abnormalities include pancytopenia and hypergammaglobulinemia. If the disease progresses in the absence of treatment, cachexia and multisystem failure, hemorrhage due to thrombocytopenia, and superimposed infections can cause death.</p><p class="" id=d22068e1493>A decrease in the number or function of CD4 cells may cause recurrence, as in the case of patients receiving corticosteroids or chemotherapy, in transplant recipients, or in association with infection with HIV; in this scenario, a new therapeutic regimen may be required<sup><a href="#ref-49">49</a><a href="#ref-51">51</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d22068e1506>Leishmaniasis and HIV</h2><p class="" id=d22068e1509>Initial data in this regard came from Southern Europe from intravenous drug abusers who share syringes, leading to a decrease in the number of T CD4 lymphocytes; in 90% of these patients, the infection represents reactivation of a previously acquired subclinical or latent infection. This immunodeficiency, in turn, leads to a lower response to treatment and frequent recurrence. No guidelines have been established to discontinue anti-parasite medications after the T CD4 cell counts increase post-treatment with the highly effective anti-retroviral treatment<sup><a href="#ref-49">49</a>,<a href="#ref-52">52</a></sup>. Similar to HIV-infected patients, pregnant women can be considered a particular population with a condition predisposing to <i>Leishmania</i> reactivation and to changes in immune response owing to a switch toward a Th2 response that has been reported during pregnancy<sup><a href="#ref-53">53</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d22068e1529>Diagnosis</h2><p class="" id=d22068e1532>Diagnosis is based on the clinical and congruent epidemiological context<sup><a href="#ref-17">17</a></sup>. Laboratory confirmation and identification of the species of <i>Leishmania</i> are important<sup><a href="#ref-2">2</a></sup>. The protozoan is found in the scraping of cutaneous or mucosal ulcerations (especially scraping the borders) as well as in non-ulcerated lesions<sup><a href="#ref-17">17</a></sup>. Biopsy is another diagnostic tool; it should be obtained from the active border of the lesion. A smear may reveal the parasites in free form or inside macrophages or less frequently in polymorphonuclear leukocytes, ranging in number from 2 to 20 in a single cell. The parasite shape is oval or piriform (with an oval or rounded nucleus) and ranges in size from 2 to 5 m long and 1 to 2 m wide. Exceptionally flagellated forms have been observed. Inoculation is also used for the culture<sup><a href="#ref-1">1</a>,<a href="#ref-17">17</a>,<a href="#ref-41">41</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d22068e1563>Histopathological data</h2><p class="" id=d22068e1566>In cases of LCL, sections stained with hematoxylin and eosin show epidermal atrophy or hyperplasia with an inflammatory infiltrate consisting of macrophages, lymphocytes, and plasma cells with focal necrotic areas. In the early stages of the infection, parasites can be recognized within cytoplasmic vacuoles in histiocytes (Leishman bodies)<sup><a href="#ref-2">2</a></sup>, and in late stages, infected macrophages are less numerous, with few amastigotes predominating, and with some lympho-histiocytic infiltrates confirming a tuberculoid granuloma. The granuloma evolves in three phases: (1) development of a mononuclear phagocytic infiltrate, (2) maturation and cellular aggregation into a disorganized granuloma, and (3) maturation of these cells into an epithelioid granuloma<sup><a href="#ref-54">54</a></sup>. Patients with diffuse CL have lesions with highly parasitized macrophages and few dermal lymphocytes<sup><a href="#ref-1">1</a>,<a href="#ref-2">2</a></sup>.</p><p class="" id=d22068e1584>Based on the Magalhaes histopathological classification, the findings are categorized into five groups: type I, which exhibits an exudative cellular reaction due to lymphocyte, histiocyte, and plasma cell infiltration without granuloma; type II, which exhibits exudative necrotic reaction characterized by cellular infiltration and necrosis without granulomas; type III, which has disorganized granulomatous necrotic and exudative granuloma corresponding to the pattern of a chronic and necrotic inflammatory reaction; type IV, which shows an exudative granulomatous reaction without necrosis and with disorganized granulomas; and type V, which exhibits an exudative tuberculoid reaction with typical organized tuberculoid granuloma. Of these types, the most frequently encountered and documented in patients with chicleros ulcer has been type IV<sup><a href="#ref-54">54</a></sup>. When special stains such as Wright-Giemsa are used, the protozoan cytoplasm stains blue and the nucleus stains red<sup><a href="#ref-17">17</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d22068e1599>Cultures</h2><p class="" id=d22068e1602>The culture is performed through the inoculation of the triturated tissue in special media. <i>Leishmania</i> is cultured in NovyMcNealNicolle medium (currently called N-N-N medium) or in a variant of the Evans biphasic medium. In the first culture, forms devoid of flagella are almost always obtained, but from the first re-seeding onwards flagellated forms appear which reach up to 50 m long<sup><a href="#ref-17">17</a></sup>. Both techniques (microscopic exam and culture) have a sensitivity of 85%<sup><a href="#ref-49">49</a>,<a href="#ref-55">55</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d22068e1622>Laboratory data</h2><p class="" id=d22068e1625>The Montenegro skin test is sensitive and specific. It is positive for the localized forms and negative in the anergic forms; a positive test supports the diagnosis (especially when the patient does not live in endemic areas), but a negative test does not exclude it<sup><a href="#ref-1">1</a></sup>. This allergic index is useful to determine whether previous contact with the parasite has occurred, even in the absence of lesions<sup><a href="#ref-19">19</a></sup>. A positive skin test is when the reaction is greater than 5 mm after 72 hours<sup><a href="#ref-18">18</a></sup>. However, intradermal injection of <i>Leishmania</i> antigen is not approved by the US Food and Drug Administration<sup><a href="#ref-56">56</a></sup>.</p><p class="" id=d22068e1647>The parasites are observed in the smear or in the imprint stained with Giemsa or Wright; this is the most common and useful diagnostic method<sup><a href="#ref-4">4</a>,<a href="#ref-18">18</a></sup>. In the case of the visceral forms, the diagnosis is performed by observing protozoans through the microscope in a tissue sample obtained by aspiration from the spleen, bone marrow, or lymph node with a sensitivity of 95%, 5597%, or 60%, respectively.</p><p class="" id=d22068e1657>Determination of serum anti-<i>Leishmania</i> IgG and the determination of anti-K39 antibodies are also used, with a sensitivity of 90 to 100% and variable specificity according to geographic area. Detection of <i>Leishmania</i> antigens in urine is a new diagnostic approach<sup><a href="#ref-49">49</a>,<a href="#ref-57">57</a></sup>.</p><p class="" id=d22068e1673>The complement fixation test is used to detect antibodies; titers equal to or above 1:8 are consistent with infection, as are titers equal to or above 1:16 in immunofluorescence tests. However, lower titers do not exclude the infection<sup><a href="#ref-9">9</a></sup>. In addition, antibodies can be detected by direct agglutination, direct immunofluorescence, and enzyme-linked immunosorbent assay<sup><a href="#ref-1">1</a>,<a href="#ref-2">2</a></sup>; however, these serological tests are infrequently recommended in CL because of their scarce availability<sup><a href="#ref-18">18</a></sup>.</p><p class="" id=d22068e1692>PCR has a reported specificity in LCL of 100% with an improved sensitivity of 20 to 30% when compared with conventional parasitology diagnosis; it can also be used in cases of mucosal leishmaniasis. Unfortunately, this method is available only in specialized laboratories or in travelers clinics<sup><a href="#ref-4">4</a></sup>.</p><p class="" id=d22068e1699>Recently, in a study in Jordan conducted by Hijjawi <i>et al</i>. using ITS1-PCR applied to 41 skin scraps on glass slides, 30 were successfully identified<sup><a href="#ref-58">58</a></sup>. Furthermore, in 28 samples, PCR-RFLP analysis allowed species identification corresponding to <i>L. major</i> and two more corresponding to <i>L. tropica</i>. However, it is still not available in medical laboratories in Jordan. For the most part, molecular amplification of the hsp70 gene fragment (PCR-hsp70) followed by RFLP analysis is a valid tool for the identification of <i>Leishmania</i> species isolated from clinical samples of patients, as was demonstrated in Colombia by Montalvo <i>et al</i>., and could be applicable to epidemiological studies<sup><a href="#ref-59">59</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d22068e1729>Prophylaxis</h2><p class="" id=d22068e1732>The eradication of the vector through insecticides, elimination of stagnant water, use of insect repellents, and prophylaxis can be achieved through the use of thick clothes with long sleeves that can be impregnated with insecticides<sup><a href="#ref-4">4</a></sup> and long pants and by avoiding night walks in jungle areas<sup><a href="#ref-17">17</a></sup>. The WHO is planning a vaccine that would protect against all types of leishmaniasis<sup><a href="#ref-44">44</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d22068e1750>Treatment</h2><p class="" id=d22068e1753>The only effective treatment with satisfactory clinical and microbiological results for all clinical forms of leishmaniasis is achieved with current intravenous pentavalent antimonials (Sb5+) in the form of sodium stibogluconate (SSG; Pentostam, UK) or meglumine antimoniate (Glucantime, France), except in the state of Bihar in India<sup><a href="#ref-49">49</a></sup>. In Bihar, parasite resistance to antimonials caused a dramatic rise in treatment failure of up to 65% between 1980 and 1997; in addition, there is the potential for resistance to miltefosine and liposomal amphotericin B to develop<sup><a href="#ref-30">30</a></sup>.</p><p class="" id=d22068e1764>It has been generally accepted that American CL, especially that caused by <i>L. braziliensis</i>, should be treated with a dose of 20 mg of Sb5+/kg per day for 20 days, especially to prevent disfiguring sequelae in mucosal lesions<sup><a href="#ref-17">17</a>,<a href="#ref-60">60</a>,<a href="#ref-61">61</a></sup>.</p><p class="" id=d22068e1780>Trivalent antimonials are prescribed parenterally (repodral and anthiomaline) in a dose of 23 mL (0.02 to 0.03 g) on alternate days for 12 to 20 days, pentavalents such as meglumine (glucantime) in a dose of 1060 mg/kg for 12 days to 3 weeks (or until clinical and parasitological evidence of cure), and SSG (Pentostam) in a dose of 20 mg/kg per day for 30 days, not necessarily consecutive; this periodicity can be determined by the onset of side effects. The drug should be diluted in 200 mL of 5% dextrose and delivered in 1 hour<sup><a href="#ref-32">32</a></sup>. Intravenous administration is used only in hospitalized patients, as intramuscular injection is very painful, but it is the only feasible alternative for treatment on a large scale.</p><p class="" id=d22068e1787>Intralesional treatment has been documented recently as the first therapeutic line in LCL caused by <i>L. major</i>, <i>L. tropica</i>, and <i>L. panamensis</i>. It causes damage to the cellular membranes and fragmentation of microtubules, preventing division of the organism. On the other hand, previous experimental studies have shown that the combination with lidocaine, besides decreasing local discomfort, favors the fragmentation and loss of morphologic definition of the plasma membrane (due to its amphophylic properties) and other organelles in the protozoa of <i>L. braziliensis</i><sup><a href="#ref-4">4</a>,<a href="#ref-62">62</a></sup>.</p><p class="" id=d22068e1809>The most frequently described adverse effects of antimonials are local irritation, anorexia, nausea, vomiting, myalgia, arthralgia, increases in hepatic enzymes, urea, and creatinine, and electrocardiographic alterations, such as inversion of the T wave, prolongation of Q-T segment, depression of the S-T segment, and sinus bradycardia. In case these effects occur, it will be necessary to stop the drug until normalization of the clinical and laboratory abnormalities, re-introducing the drug on alternate days<sup><a href="#ref-2">2</a>,<a href="#ref-32">32</a></sup>.</p><p class="" id=d22068e1819>In the diffuse form, pentamidine is useful and is the second choice. Each flask has 300 mg of the drug, a dose that should be diluted in 5 mL of distilled water to be applied intramuscularly in the gluteus. The dose is 4 mg/kg with a maximum dose of 240 mg per day on alternate days. The total dose is dependent on the clinical response and the adverse effects, including nephrotoxicity, hepatotoxicity, hypertension, hypoglycemia, hyperglycemia (rarely), electrocardiographic alterations, gluteal abscess, central facial paresthesia, cephalea, epigastralgia, and vertigo.</p><p class="" id=d22068e1822>For treatment of the muco-cutaneous forms, the duration of a parenteral therapeutic regimen with antimonials is 28 days, achieving a cure rate of about 75% in patients with mild or moderate forms; it is lower in patients with more severe clinical forms, in whom amphotericin B is used as a rescue treatment, and in patients with anergic forms<sup><a href="#ref-49">49</a>,<a href="#ref-63">63</a></sup>.</p><p class="" id=d22068e1832>Treatment failure for VL with pentavalent antimonial (SSG) has been reported in recent years in Nepal; as a result, liposomal amphotericin B is currently recommended by the National Program of Nepal for kala-azar treatment<sup><a href="#ref-15">15</a></sup>.</p><p class="" id=d22068e1839>The drug also results in a good response in immunocompromised patients, but the percentage of recurrences in these patients is high. Amphotericin B is an extremely effective but toxic alternative; it is effective even in forms resistant to antimonials. The dose is l mg/kg per day with a maximum of 50 mg per dose. It is prepared by diluting it in 500 mL of 5% dextrose and delivered on alternate days up to a total dose of 1 to 1.5 g, while liposomal amphotericin is used at 2 to 3 mg/kg as a total dose over the course of 20 days.</p><p class="" id=d22068e1842>Clinical improvement is observed from 7 to 10 days after therapy is initiated; after 2 weeks of treatment, the clinical cure is almost complete with cessation of fever, decrease in size of the spleen, and absence of amastigotes in the aspirate.</p><p class="" id=d22068e1846>An alternative is the transfer factor and more recently paromomycin, which has finished phase III experimental studies in India and Africa and has been approved in some cases<sup><a href="#ref-49">49</a>,<a href="#ref-64">64</a></sup>. In some cases of CL, diaminodiphenyl sulfone (Dapsone<sup></sup>) has been useful at a dose of 3 mg/kg per day for 3 weeks<sup><a href="#ref-1">1</a>,<a href="#ref-2">2</a>,<a href="#ref-32">32</a></sup>.</p><p class="" id=d22068e1869>In cases caused by <i>L. mexicana</i>, there is a good response to ketoconazole 200 to 400 mg per day for 4 to 6 weeks with or without cryotherapy<sup><a href="#ref-2">2</a>,<a href="#ref-65">65</a></sup> or itraconazole 200 to 400 mg per day for 1 to 2 months<sup><a href="#ref-32">32</a></sup>. Fluconazole has not been demonstrated to be effective as a therapeutic option<sup><a href="#ref-66">66</a></sup>.</p><p class="" id=d22068e1890>Other alternatives include rifampicin 600 to 1,200 mg per day for more than 2 months, either alone or with isoniazid, IFN at a dose of 50 to 100 m/m<sup>2</sup> per day (subcutaneously for 10 to 15 days, although it is not curative if used alone), recombinant human granulocyte-macrophage colony-stimulating factor (rHGM-CSF) at subcutaneous doses of 5 g/kg per day for 10 days or intralesional 200 g per dose, metronidazole 250 mg three times a day in cycles of 10 to 15 days, trimethoprim-sulfamethoxazole 160/800 mg twice a day for 4 weeks, azithromycin at a dose of 500 mg per day for 3, 5, and 10 days or 1 g per day for 2 days, and pentoxifylline in doses of 1,200 mg per day for 30 days<sup><a href="#ref-32">32</a></sup>.</p><p class="" id=d22068e1900>Clinical studies with paromomycin and miltefosine have shown them to be useful; currently, the combination of thermotherapy and miltefosine has been considered as an effective alternative in the treatment of CL<sup><a href="#ref-4">4</a>,<a href="#ref-67">67</a>,<a href="#ref-68">68</a></sup>.</p><p class="" id=d22068e1913>A randomized phase IIIII clinical trial conducted in Brazil with 90 patients with confirmed CL due to <i>L. guyanensis</i> to compare miltefosine versus parenteral antimonials revealed cure rates of 71.4% and 53.6%, respectively, with no statistically significant differences between age groups within the same treatment arms<sup><a href="#ref-69">69</a></sup>. However, in a phase II open-label, non-comparative randomized trial conducted in Sudan and Kenya to evaluate the efficacy and safety of three treatment regimens for VL caused by <i>L. donovani</i> based on the combination of liposomal amphotericin, SSG, and miltefosine divided into three arms of 50 patients each, the results demonstrated cure ratios of 87% for liposomal amphotericin plus SSG, 77% for liposomal amphotericin plus miltefosine, and 72% for miltefosine alone, and efficacy was lower in younger patients; therefore, none of these regimes achieves cure ratios of 90%, so they should not be used as monotherapy<sup><a href="#ref-70">70</a></sup>.</p><p class="" id=d22068e1930>Locally, one can use antiseptics such as 15% paromomycin sulfate and 12% methylbenzethonium ointment twice daily for 10 days to 3 weeks. Another alternative in the local treatment of LCL is the injection of intralesional amphotericin, which has demonstrated its effectiveness using 2.5 mg/mL weekly without recurrences after a 6-month period of follow-up in a study performed by Mushtaq <i>et al</i>. in India<sup><a href="#ref-71">71</a></sup>. Thermotherapy, cryosurgery, curettage, and laser and radiotherapy have been tried with relative efficacy<sup><a href="#ref-1">1</a>,<a href="#ref-4">4</a>,<a href="#ref-72">72</a>,<a href="#ref-73">73</a></sup>. Sometimes, in spite of successful treatment, recurrent lesions have been reported<sup><a href="#ref-74">74</a></sup>. Immunotherapy that combines topical imiquimod with systemic antimonials and vaccines against the sand fly will be fundamental for the future treatment and prevention of leishmaniasis<sup><a href="#ref-75">75</a></sup>.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d22068e1 class=n-a></a><h2 class=main-title id=d22376>Competing interests</h2><p class=metadata-entry><a name=d22068e127 class=n-a></a><p id=d22068e129> The authors declare that they have no competing interests.</p></p></div><div class=back-section><a name=d22068e1 class=n-a></a><h2 class=main-title id=d22378>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d22068e1965 class=n-a></a><h2 class=main-title id=d22068e1967>Acknowledgments</h2><p class="" id=d22068e1970>The authors acknowledge the assistance of Juan Carlos Manivel, of the Department of Pathology, Veterans Administration Medical Center, Minneapolis, MN, USA, and Francisco G. Bravo, Associate Professor, Department of Pathology, Universidad Peruana Cayetano Heredia, Lima, Peru.</p></div><div class=back-section><a name=d22068e1974 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d22596>References</h2><div class="section ref-list"><a name=d22068e1974 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d22068e1981 class=n-a></a>Vera-Izaguirre D, Vega-Memije E, Quintanilla Cedillo M, <i> et al.</i>: Leishmaniasis revisin. <i>DCMQ.</i> 2006; <b>4</b>(4): 252260. <a target=xrefwindow id=d22068e1992 href="http://new.medigraphic.com/cgi-bin/resumen.cgi?IDARTICULO=56287">Reference Source</a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d22068e2001 class=n-a></a>Vargas-Martnez F, Torres-Guerrero E, Quintanilla-Cedillo MR, <i> et al.</i>: Leishmaniasis en Mxico. Academia Mexicana de Dermatologa, Colegio de Dermatlogos de Yucatn A. C., Fundacin Mexicana para la Dermatologa, Universidad Autnoma de Campeche y Secretara de Salud, Mxico. 2013. </span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d22068e2013 class=n-a></a>Andrade-Narvez FJ, Vargas-Gonzlez A, Canto-Lara SB, <i> et al.</i>: Clinical picture of cutaneous leishmaniases due to <i>Leishmania (Leishmania)</i> mexicana in the Yucatan peninsula, Mexico. <i>Mem Inst Oswaldo Cruz.</i> 2001; <b>96</b>(2): 1637. <a target=xrefwindow id=d22068e2027 href="http://www.ncbi.nlm.nih.gov/pubmed/11285491">PubMed Abstract </a> | <a target=xrefwindow id=d22068e2031 href="http://dx.doi.org/10.1590/S0074-02762001000200005">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1103847"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22068e2040 class=n-a></a>Reithinger R, Dujardin J, Louzir H, <i> et al.</i>: Cutaneous leishmaniasis. <i>Lancet Infect Dis.</i> 2007; <b>7</b>(9): 58196. <a target=xrefwindow id=d22068e2051 href="http://www.ncbi.nlm.nih.gov/pubmed/17714672">PubMed Abstract </a> | <a target=xrefwindow id=d22068e2054 href="http://dx.doi.org/10.1016/S1473-3099(07)70209-8">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1103847">F1000 Recommendation</a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d22068e2067 class=n-a></a>Kashif M, Manna PP, Akhter Y, <i> et al.</i>: The Screening of novel inhibitors against Leishmania donovani Calcium ion channel to fight Leishmaniasis. <i>Infect Disord Drug Targets.</i> 2016; <b>16</b>. <a target=xrefwindow id=d22068e2078 href="http://www.ncbi.nlm.nih.gov/pubmed/28034363">PubMed Abstract </a> | <a target=xrefwindow id=d22068e2081 href="http://dx.doi.org/10.2174/1871526516666161230124513">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d22068e2091 class=n-a></a>Hoyos CL, Cajal SP, Juarez M, <i> et al.</i>: Epidemiology of American Tegumentary Leishmaniasis and <i>Trypanosoma cruzi</i> Infection in the Northwestern Argentina. <i>Biomed Res Int.</i> 2016; <b>2016</b>: 6456031. <a target=xrefwindow id=d22068e2105 href="http://www.ncbi.nlm.nih.gov/pubmed/27777950">PubMed Abstract </a> | <a target=xrefwindow id=d22068e2109 href="http://dx.doi.org/10.1155/2016/6456031">Publisher Full Text </a> | <a target=xrefwindow id=d22068e2112 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5061991">Free Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d22068e2121 class=n-a></a>Albertos-Alpuche N: Vectores de la leishmaniasis cutnea en Mxico. <i>Rev Biomed.</i> 1990; <b>1</b>(2): 92102. <a target=xrefwindow id=d22068e2129 href="http://www.revbiomed.uady.mx/pdf/rb90125.pdf">Reference Source</a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d22068e2138 class=n-a></a>Miranda O, Gonzlez I: Leishmaniasis cutnea. Presentacin de casos. <i>Rev Cub Med Mil.</i> 2007: <b>36</b>(4); 5154. <a target=xrefwindow id=d22068e2146 href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S0138-65572007000400011">Reference Source</a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d22068e2155 class=n-a></a>Bravo F, Sanchez MR: New and re-emerging cutaneous infectious diseases in Latin America and other geographic areas. <i>Dermatol Clin.</i> 2003; <b>21</b>(4): 65568, viii. <a target=xrefwindow id=d22068e2163 href="http://www.ncbi.nlm.nih.gov/pubmed/14717406">PubMed Abstract </a> | <a target=xrefwindow id=d22068e2166 href="http://dx.doi.org/10.1016/S0733-8635(03)00090-1">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d22068e2175 class=n-a></a>World Health Organization: Weekly Epidemiological Record (WER). 2016; <b>91</b>(22): 285296. <a target=xrefwindow id=d22068e2180 href="http://www.who.int/wer/2016/wer9122/en/">Reference Source</a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727620479"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22068e2189 class=n-a></a>Ozkeklikci A, Karakus M, Ozbel Y, <i> et al.</i>: The new situation of cutaneous leishmaniasis after Syrian civil war in Gaziantep city, Southeastern region of Turkey. <i>Acta Trop.</i> 2017; <b>166</b>: 358. <a target=xrefwindow id=d22068e2200 href="http://www.ncbi.nlm.nih.gov/pubmed/27983970">PubMed Abstract </a> | <a target=xrefwindow id=d22068e2203 href="http://dx.doi.org/10.1016/j.actatropica.2016.10.019">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727620479">F1000 Recommendation</a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727620483"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22068e2217 class=n-a></a>Khezzani B, Bouchemal S: Demographic and spatio-temporal distribution of cutaneous leishmaniasis in the <i>Souf</i> oasis (Eastern South of Algeria): Results of 13 years. <i>Acta Trop.</i> 2017; <b>166</b>: 7480. <a target=xrefwindow id=d22068e2228 href="http://www.ncbi.nlm.nih.gov/pubmed/27840067">PubMed Abstract </a> | <a target=xrefwindow id=d22068e2231 href="http://dx.doi.org/10.1016/j.actatropica.2016.11.012">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727620483">F1000 Recommendation</a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727620485"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22068e2244 class=n-a></a>Holakouie-Naieni K, Mostafavi E, Boloorani AD, <i> et al.</i>: Spatial modeling of cutaneous leishmaniasis in Iran from 1983 to 2013. <i>Acta Trop.</i> 2017; <b>166</b>: 6773. <a target=xrefwindow id=d22068e2255 href="http://www.ncbi.nlm.nih.gov/pubmed/27836499">PubMed Abstract </a> | <a target=xrefwindow id=d22068e2258 href="http://dx.doi.org/10.1016/j.actatropica.2016.11.004">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727620485">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727620487"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22068e2271 class=n-a></a>Khosravani M, Moemenbellah-Fard MD, Sharafi M, <i> et al.</i>: Epidemiologic profile of oriental sore caused by <i>Leishmania</i> parasites in a new endemic focus of cutaneous leishmaniasis, southern Iran. <i>J Parasit Dis.</i> 2016; <b>40</b>(3): 107781. <a target=xrefwindow id=d22068e2285 href="http://www.ncbi.nlm.nih.gov/pubmed/27605840">PubMed Abstract </a> | <a target=xrefwindow id=d22068e2289 href="http://dx.doi.org/10.1007/s12639-014-0637-x">Publisher Full Text </a> | <a target=xrefwindow id=d22068e2292 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4996250">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727620487">F1000 Recommendation</a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d22068e2305 class=n-a></a>Pandey BD, Pun SB, Kaneko O, <i> et al.</i>: Case report: Expansion of visceral leishmaniasis to the western hilly part of Nepal. <i>Am J Trop Med Hyg.</i> 2011; <b>84</b>(1): 1078. <a target=xrefwindow id=d22068e2316 href="http://www.ncbi.nlm.nih.gov/pubmed/21212211">PubMed Abstract </a> | <a target=xrefwindow id=d22068e2319 href="http://dx.doi.org/10.4269/ajtmh.2011.10-0291">Publisher Full Text </a> | <a target=xrefwindow id=d22068e2323 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3005498">Free Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d22068e2332 class=n-a></a>Cruz Ruiz AL, Garca-Miss MR: Incriminacin del Sand Fly como vector de leishmania. <i>Rev Biomed.</i> 1990; <b>1</b>(2): 103108. <a target=xrefwindow id=d22068e2340 href="http://www.revbiomed.uady.mx/pdf/rb90126.pdf">Reference Source</a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d22068e2349 class=n-a></a>Inchustegui A: De la leishmaniosis americana y de la lcera de los chicleros en Mxico. Tesis, Universidad Nacional de Mxico. 1918. </span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d22068e2359 class=n-a></a>Cordova-Uscanga C, Albertos-Alpuche NE, Andrade-Narvaez FJ, <i> et al.</i>: Leishmaniasis: estudio epidemiologico preliminar en una localidad de la zona endemica del estado de Tabasco. <i>Salud Publica Mex.</i> 1993; <b>35</b>(4): 34550. <a target=xrefwindow id=d22068e2370 href="http://www.redalyc.org/pdf/106/10635404.pdf">Reference Source</a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d22068e2379 class=n-a></a>Vazquez Perez A, Burgos Patron JP, Andrade Narvaez FJ, <i> et al.</i>: Leishmaniasis cutanea localizada: indice alergico en la comunidad de becanchen, tekax, yucatan, Mxico. <i>Rev Biomed.</i> 1996; <b>7</b>(1): 1118. <a target=xrefwindow id=d22068e2390 href="http://biblat.unam.mx/pt/revista/revista-biomedica-universidad-autonoma-de-yucatan/articulo/leishmaniasis-cutanea-localizada-indice-alergico-en-la-comunidad-de-becanchen-tekax-yucatan-mexico">Reference Source</a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d22068e2399 class=n-a></a>Canto-Lara SB, Cardenas-Maruffo MF, Vargas-Gonzalez A, <i> et al.</i>: Isoenzyme characterization of Leishmania isolated from human cases with localized cutaneous leishmaniasis from the State of Campeche, Yucatan Peninsula, Mexico. <i>Am J Trop Med Hyg.</i> 1998; <b>58</b>(4): 4447. <a target=xrefwindow id=d22068e2410 href="http://www.ncbi.nlm.nih.gov/pubmed/9574789">PubMed Abstract </a> | <a target=xrefwindow id=d22068e2413 href="http://dx.doi.org/10.4269/ajtmh.1998.58.444">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d22068e2422 class=n-a></a>Andrade-Narvez FJ, Simmonds-Daz E, Rico-Aguilar S, <i> et al.</i>: Incidence of localized cutaneous leishmaniasis (chiclero's ulcer) in Mexico. <i>Trans R Soc Trop Med Hyg.</i> 1990; <b>84</b>(2): 21920. <a target=xrefwindow id=d22068e2433 href="http://www.ncbi.nlm.nih.gov/pubmed/2389310">PubMed Abstract </a> | <a target=xrefwindow id=d22068e2436 href="http://dx.doi.org/10.1016/0035-9203(90)90262-D">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d22068e2445 class=n-a></a>van Wynsberghe NR, Canto-Lara SB, Sosa-Bibiano EI, <i> et al.</i>: Comparison of small mammal prevalence of <i>Leishmania (Leishmania) mexicana</i> in five foci of cutaneous leishmaniasis in the State of Campeche, Mexico. <i>Rev Inst Med Trop Sao Paulo.</i> 2009; <b>51</b>(2): 8794. <a target=xrefwindow id=d22068e2459 href="http://www.ncbi.nlm.nih.gov/pubmed/19390737">PubMed Abstract </a> | <a target=xrefwindow id=d22068e2463 href="http://dx.doi.org/10.1590/S0036-46652009000200006">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d22068e2472 class=n-a></a>Andrade-Narvaez FJ, Canto Lara SB, van Wynsberghe NR, <i> et al.</i>: Seasonal transmission of <i>Leishmania (Leishmania) mexicana</i> in the state of Campeche, Yucatan Peninsula, Mexico. <i>Mem Inst Oswaldo Cruz.</i> 2003; <b>98</b>(8): 9958. <a target=xrefwindow id=d22068e2486 href="http://www.ncbi.nlm.nih.gov/pubmed/15049078">PubMed Abstract </a> | <a target=xrefwindow id=d22068e2490 href="http://dx.doi.org/10.1590/S0074-02762003000800002">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d22068e2500 class=n-a></a>Andrade Narvez F, Valerio Castro E, Simmonds Daz E, <i> et al.</i>: Leishmaniasis cutnea mexicana. ndice alrgico en una poblacin militar ubicada en una zona epidmica. <i>Rev Sanid Milit Mx.</i> 1985; <b>39</b>(5): 152154.</span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d22068e2518 class=n-a></a>Rebollar-Tllez EA, Ramrez-Fraire A, Andrade-Narvaez FJ: A two years study on vectors of cutaneous leishmaniasis. Evidence for sylvatic transmission cycle in the State of Campeche, Mexico. <i>Mem Inst Oswaldo Cruz.</i> 1996; <b>91</b>(5): 55560. <a target=xrefwindow id=d22068e2526 href="http://www.ncbi.nlm.nih.gov/pubmed/9137741">PubMed Abstract </a> | <a target=xrefwindow id=d22068e2529 href="http://dx.doi.org/10.1590/S0074-02761996000500004">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727622362"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22068e2538 class=n-a></a>Thies SF, Bronzoni RV, Espinosa MM, <i> et al.</i>: Frequency and diversity of phlebotomine sand flies (Diptera: Psychodidae) in Sinop, State of Mato Grosso, Brazil. <i>Rev Soc Bras Med Trop.</i> 2016; <b>49</b>(5): 54452. <a target=xrefwindow id=d22068e2549 href="http://www.ncbi.nlm.nih.gov/pubmed/27812647">PubMed Abstract </a> | <a target=xrefwindow id=d22068e2552 href="http://dx.doi.org/10.1590/0037-8682-0251-2016">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727622362">F1000 Recommendation</a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727622363"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22068e2565 class=n-a></a>Vita GF, Pereira MA, Ferreira I, <i> et al.</i>: Status of the American tegumentary Leishmaniasis in the State of <i>Rio de Janeiro</i> , Brazil, from 2004 to 2013. <i>Rev Inst Med Trop Sao Paulo.</i> 2016; <b>58</b>: 71. <a target=xrefwindow id=d22068e2579 href="http://www.ncbi.nlm.nih.gov/pubmed/27680176">PubMed Abstract </a> | <a target=xrefwindow id=d22068e2583 href="http://dx.doi.org/10.1590/S1678-9946201658071">Publisher Full Text </a> | <a target=xrefwindow id=d22068e2586 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5048642">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727622363">F1000 Recommendation</a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726408448"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22068e2599 class=n-a></a>Al-Jawabreh A, Dumaidi K, Ereqat S, <i> et al.</i>: Molecular epidemiology of human cutaneous leishmaniasis in Jericho and its vicinity in Palestine from 1994 to 2015. <i>Infect Genet Evol.</i> 2017; <b>50</b>: 95101. <a target=xrefwindow id=d22068e2610 href="http://www.ncbi.nlm.nih.gov/pubmed/27268151">PubMed Abstract </a> | <a target=xrefwindow id=d22068e2613 href="http://dx.doi.org/10.1016/j.meegid.2016.06.007">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726408448">F1000 Recommendation</a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726278528"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22068e2626 class=n-a></a>Fakhar M, Pazoki Ghohe H, Rasooli SA, <i> et al.</i>: Genetic diversity of <i>Leishmania tropica</i> strains isolated from clinical forms of cutaneous leishmaniasis in rural districts of Herat province, Western Afghanistan, based on ITS1-rDNA. <i>Infect Genet Evol.</i> 2016; <b>41</b>: 1207. <a target=xrefwindow id=d22068e2640 href="http://www.ncbi.nlm.nih.gov/pubmed/27063410">PubMed Abstract </a> | <a target=xrefwindow id=d22068e2644 href="http://dx.doi.org/10.1016/j.meegid.2016.03.031">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726278528">F1000 Recommendation</a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726608909"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22068e2658 class=n-a></a>Hirve S, Boelaert M, Matlashewski G, <i> et al.</i>: Transmission Dynamics of Visceral Leishmaniasis in the Indian Subcontinent - A Systematic Literature Review. <i>PLoS Negl Trop Dis.</i> 2016; <b>10</b>(8): e0004896. <a target=xrefwindow id=d22068e2669 href="http://www.ncbi.nlm.nih.gov/pubmed/27490264">PubMed Abstract </a> | <a target=xrefwindow id=d22068e2672 href="http://dx.doi.org/10.1371/journal.pntd.0004896">Publisher Full Text </a> | <a target=xrefwindow id=d22068e2676 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4973965">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726608909">F1000 Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726919559"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22068e2689 class=n-a></a>Oryan A, Akbari M: Worldwide risk factors in leishmaniasis. <i>Asian Pac J Trop Med.</i> 2016; <b>9</b>(10): 92532. <a target=xrefwindow id=d22068e2697 href="http://www.ncbi.nlm.nih.gov/pubmed/27794384">PubMed Abstract </a> | <a target=xrefwindow id=d22068e2700 href="http://dx.doi.org/10.1016/j.apjtm.2016.06.021">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726919559">F1000 Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d22068e2713 class=n-a></a>Azulay D, Rubem Azulay D, Azulay A: Dermatologa. 4ta Ed. Ediciones Guanabara Koogan, Ro de Janeiro. 2008; 415425.</span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d22068e2722 class=n-a></a>Van Wynsberghe NR, Canto-Lara SB, Damin-Centeno AG, <i> et al.</i>: Retention of <i>Leishmania (Leishmania) mexicana</i> in naturally infected rodents from the State of Campeche, Mexico. <i>Mem Inst Oswaldo Cruz.</i> 2000; <b>95</b>(5): 595600. <a target=xrefwindow id=d22068e2736 href="http://www.ncbi.nlm.nih.gov/pubmed/10998205">PubMed Abstract </a> | <a target=xrefwindow id=d22068e2740 href="http://dx.doi.org/10.1590/S0074-02762000000500001">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726472352"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22068e2749 class=n-a></a>Wetzel DM, Rhodes EL, Li S, <i> et al.</i>: The Src kinases Hck, Fgr and Lyn activate Arg to facilitate IgG-mediated phagocytosis and <i>Leishmania</i> infection. <i>J Cell Sci.</i> 2016; <b>129</b>(16): 313043. <a target=xrefwindow id=d22068e2763 href="http://www.ncbi.nlm.nih.gov/pubmed/27358479">PubMed Abstract </a> | <a target=xrefwindow id=d22068e2767 href="http://dx.doi.org/10.1242/jcs.185595">Publisher Full Text </a> | <a target=xrefwindow id=d22068e2770 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5004897">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726472352">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d22068e2783 class=n-a></a>Garca Miss M: Cellular response to leishmaniasis. <i>Rev Biomed.</i> 1995; <b>6</b>: 92100. <a target=xrefwindow id=d22068e2791 href="http://www.revbiomed.uady.mx/pdf/rb95626.pdf">Reference Source</a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d22068e2801 class=n-a></a>Chang KP, Reed SG, McGwire BS, <i> et al.</i>: <i>Leishmania</i> model for microbial virulence: the relevance of parasite multiplication and pathoantigenicity. <i>Acta Trop.</i> 2003; <b>85</b>(3): 375390. <a target=xrefwindow id=d22068e2815 href="http://www.ncbi.nlm.nih.gov/pubmed/12659975">PubMed Abstract </a> | <a target=xrefwindow id=d22068e2819 href="http://dx.doi.org/10.1016/S0001-706X(02)00238-3">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d22068e2828 class=n-a></a>Melby PC, Andrade-Narvaez F, Darnell BJ, <i> et al.</i>: <i>In situ</i> expression of interleukin-10 and interleukin-12 in active human cutaneous leishmaniasis. <i>FEMS Immunol Med Microbiol.</i> 1996; <b>15</b>(2-3): 1017. <a target=xrefwindow id=d22068e2842 href="http://www.ncbi.nlm.nih.gov/pubmed/8880134">PubMed Abstract </a> | <a target=xrefwindow id=d22068e2846 href="http://dx.doi.org/10.1111/j.1574-695X.1996.tb00059.x">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d22068e2855 class=n-a></a>Melby PC, Andrade-Narvaez FJ, Darnell BJ, <i> et al.</i>: Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasis. <i>Infect Immun.</i> 1994; <b>62</b>(3): 83742. <a target=xrefwindow id=d22068e2866 href="http://www.ncbi.nlm.nih.gov/pubmed/8112853">PubMed Abstract </a> | <a target=xrefwindow id=d22068e2869 href="http://www.ncbi.nlm.nih.gov/pmc/articles/186190">Free Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d22068e2878 class=n-a></a>Romero GA, Guerra MV, Paes MG, <i> et al.</i>: Comparison of cutaneous leishmaniasis due to <i>Leishmania</i> (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate. <i>Am J Trop Med Hyg.</i> 2001; <b>65</b>(5): 45665. <a target=xrefwindow id=d22068e2892 href="http://www.ncbi.nlm.nih.gov/pubmed/11716098">PubMed Abstract </a> | <a target=xrefwindow id=d22068e2896 href="http://dx.doi.org/10.4269/ajtmh.2001.65.456">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726286364"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22068e2905 class=n-a></a>Schaut RG, Lamb IM, Toepp AJ, <i> et al.</i>: Regulatory IgD<sup>hi</sup> B Cells Suppress T Cell Function via IL-10 and PD-L1 during Progressive Visceral Leishmaniasis. <i>J Immunol.</i> 2016; <b>196</b>(10): 41009. <a target=xrefwindow id=d22068e2919 href="http://www.ncbi.nlm.nih.gov/pubmed/27076677">PubMed Abstract </a> | <a target=xrefwindow id=d22068e2923 href="http://dx.doi.org/10.4049/jimmunol.1502678">Publisher Full Text </a> | <a target=xrefwindow id=d22068e2926 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4868652">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726286364">F1000 Recommendation</a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d22068e2939 class=n-a></a>Seidelin H: <i>Leishmaniasis</i> and <i>Babesiasis</i> in Yucatan. <i>Ann Trop Med Parasit.</i> 2016; <b>6</b>(2): 295300. <a target=xrefwindow id=d22068e2953 href="http://dx.doi.org/10.1080/00034983.1912.11687069">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d22068e2963 class=n-a></a>Dowlati Y: Cutaneous leishmaniasis: clinical aspects. <i>Clin Dermatol.</i> 1996; <b>14</b>(5): 42531. <a target=xrefwindow id=d22068e2971 href="http://www.ncbi.nlm.nih.gov/pubmed/8889320">PubMed Abstract </a> | <a target=xrefwindow id=d22068e2974 href="http://dx.doi.org/10.1016/0738-081X(96)00058-2">Publisher Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d22068e2983 class=n-a></a>Soto JM, Toledo JT, Gutierrez P, <i> et al.</i>: Treatment of cutaneous leishmaniasis with a topical antileishmanial drug (WR279396): phase 2 pilot study. <i>Am J Trop Med Hyg.</i> 2002; <b>66</b>(2): 14751. <a target=xrefwindow id=d22068e2994 href="http://www.ncbi.nlm.nih.gov/pubmed/12135285">PubMed Abstract </a> | <a target=xrefwindow id=d22068e2997 href="http://dx.doi.org/10.4269/ajtmh.2002.66.147">Publisher Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d22068e3006 class=n-a></a>Arenas R: Dermatologa, Atlas diagnstico y tratamiento. 6ta Ed. Mxico, McGraw Hill, 2015; 465472. <a target=xrefwindow id=d22068e3008 href="https://accessmedicina.mhmedical.com/book.aspx?bookID=1538">Reference Source</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d22068e3017 class=n-a></a>Davies CR, Reithinger R, Campbell-Lendrum D, <i> et al.</i>: The epidemiology and control of leishmaniasis in Andean countries. <i>Cad Saude Publica.</i> 2000; <b>16</b>(4): 92550. <a target=xrefwindow id=d22068e3028 href="http://www.ncbi.nlm.nih.gov/pubmed/11175518">PubMed Abstract </a> | <a target=xrefwindow id=d22068e3031 href="http://dx.doi.org/10.1590/S0102-311X2000000400013">Publisher Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d22068e3040 class=n-a></a>Marsden PD: Mucosal leishmaniasis (espundia Escomel, 1911). <i>Trans R Soc Trop Med Hyg.</i> 1986; <b>80</b>(6): 85976. <a target=xrefwindow id=d22068e3048 href="http://www.ncbi.nlm.nih.gov/pubmed/3037735">PubMed Abstract </a> | <a target=xrefwindow id=d22068e3051 href="http://dx.doi.org/10.1016/0035-9203(86)90243-9">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d22068e3060 class=n-a></a>Desjeux P: Leishmaniasis: current situation and new perspectives. <i>Comp Immunol Microbiol Infect Dis.</i> 2004; <b>27</b>(5): 30518. <a target=xrefwindow id=d22068e3068 href="http://www.ncbi.nlm.nih.gov/pubmed/15225981">PubMed Abstract </a> | <a target=xrefwindow id=d22068e3071 href="http://dx.doi.org/10.1016/j.cimid.2004.03.004">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d22068e3081 class=n-a></a>Guerin PJ, Olliaro P, Sundar S, <i> et al.</i>: Visceral leishmaniasis: Current status of control, diagnosis, and treatment, and a proposed research and development agenda. <i>Lancet Infect Dis.</i> 2002; <b>2</b>(8): 494501. <a target=xrefwindow id=d22068e3092 href="http://www.ncbi.nlm.nih.gov/pubmed/12150849">PubMed Abstract </a> | <a target=xrefwindow id=d22068e3095 href="http://dx.doi.org/10.1016/S1473-3099(02)00347-X">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d22068e3104 class=n-a></a>Murray HW, Berman JD, Davies CR, <i> et al.</i>: Advances in leishmaniasis. <i>Lancet.</i> 2005; <b>366</b>(9496): 156177. <a target=xrefwindow id=d22068e3115 href="http://www.ncbi.nlm.nih.gov/pubmed/16257344">PubMed Abstract </a> | <a target=xrefwindow id=d22068e3118 href="http://dx.doi.org/10.1016/s0140-6736(05)67629-5">Publisher Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d22068e3127 class=n-a></a>Collin S, Davidson R, Ritmeijer K, <i> et al.</i>: Conflict and kala-azar: determinants of adverse outcomes of kala-azar among patients in southern Sudan. <i>Clin Infect Dis.</i> 2004; <b>38</b>(5): 6129. <a target=xrefwindow id=d22068e3138 href="http://www.ncbi.nlm.nih.gov/pubmed/14986243">PubMed Abstract </a> | <a target=xrefwindow id=d22068e3141 href="http://dx.doi.org/10.1086/381203">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727622365"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22068e3150 class=n-a></a>Kumar Bhat N, Ahuja V, Dhar M, <i> et al.</i>: Changing Epidemiology: A New Focus of Kala-azar at High-Altitude Garhwal Region of North India. <i>J Trop Pediatr.</i> 2017; <b>63</b>(2): 1048. <a target=xrefwindow id=d22068e3161 href="http://www.ncbi.nlm.nih.gov/pubmed/27582128">PubMed Abstract </a> | <a target=xrefwindow id=d22068e3164 href="http://dx.doi.org/10.1093/tropej/fmw056">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727622365">F1000 Recommendation</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d22068e3177 class=n-a></a>Berenguer J, Cosn J, Miralles P, <i> et al.</i>: Discontinuation of secondary anti-leishmania prophylaxis in HIV-infected patients who have responded to highly active antiretroviral therapy. <i>AIDS.</i> 2000; <b>14</b>(18): 29468. <a target=xrefwindow id=d22068e3188 href="http://www.ncbi.nlm.nih.gov/pubmed/11153679">PubMed Abstract </a> | <a target=xrefwindow id=d22068e3191 href="http://dx.doi.org/10.1097/00002030-200012220-00020">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727144948"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22068e3200 class=n-a></a>Pagliano P, Ascione T, Di Flumeri G, <i> et al.</i>: Visceral leishmaniasis in immunocompromised: diagnostic and therapeutic approach and evaluation of the recently released IDSA guidelines. <i>Infez Med.</i> 2016; <b>24</b>(4): 26571. <a target=xrefwindow id=d22068e3211 href="http://www.ncbi.nlm.nih.gov/pubmed/28011960">PubMed Abstract </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727144948">F1000 Recommendation</a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d22068e3225 class=n-a></a>Andrade-Narvaez FJ, Medina-Peralta S, Vargas-Gonzalez A, <i> et al.</i>: The histopathology of cutaneous leishmaniasis due to <i>Leishmania (Leishmania) mexicana</i> in the Yucatan peninsula, Mexico. <i>Rev Inst Med Trop Sao Paulo.</i> 2005; <b>47</b>(4): 1914. <a target=xrefwindow id=d22068e3239 href="http://www.ncbi.nlm.nih.gov/pubmed/16138198">PubMed Abstract </a> | <a target=xrefwindow id=d22068e3243 href="http://dx.doi.org/10.1590/S0036-46652005000400003">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d22068e3252 class=n-a></a>Ramrez JR, Agudelo S, Muskus C, <i> et al.</i>: Diagnosis of cutaneous leishmaniasis in Colombia: the sampling site within lesions influences the sensitivity of parasitologic diagnosis. <i>J Clin Microbiol.</i> 2000; <b>38</b>(10): 376873. <a target=xrefwindow id=d22068e3263 href="http://www.ncbi.nlm.nih.gov/pubmed/11015400">PubMed Abstract </a> | <a target=xrefwindow id=d22068e3266 href="http://www.ncbi.nlm.nih.gov/pmc/articles/87473">Free Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d22068e3275 class=n-a></a>Arenas R: Leishmaniasis. In: Arenas R, Estrada R: <i>Tropical Dermatology</i>. 1era Ed. Texas. Landes Bioscience; 2001; 228238. </span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d22068e3287 class=n-a></a>Sundar S, Sahu M, Mehta H, <i> et al.</i>: Noninvasive management of Indian visceral leishmaniasis: clinical application of diagnosis by K39 antigen strip testing at a kala-azar referral unit. <i>Clin Infect Dis.</i> 2002; <b>35</b>(5): 5816. <a target=xrefwindow id=d22068e3298 href="http://www.ncbi.nlm.nih.gov/pubmed/12173133">PubMed Abstract </a> | <a target=xrefwindow id=d22068e3301 href="http://dx.doi.org/10.1086/342057">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727622366"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22068e3310 class=n-a></a>Hijjawi N, Kanani KA, Rasheed M, <i> et al.</i>: Molecular Diagnosis and Identification of <i>Leishmania</i> Species in Jordan from Saved Dry Samples. <i>Biomed Res Int.</i> 2016; <b>2016</b>: 6871739. <a target=xrefwindow id=d22068e3324 href="http://www.ncbi.nlm.nih.gov/pubmed/27403435">PubMed Abstract </a> | <a target=xrefwindow id=d22068e3328 href="http://dx.doi.org/10.1155/2016/6871739">Publisher Full Text </a> | <a target=xrefwindow id=d22068e3331 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4926024">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727622366">F1000 Recommendation</a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727622367"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22068e3344 class=n-a></a>Montalvo AM, Fraga J, Montano I, <i> et al.</i>: Molecular identification of Leishmania spp. clinical isolates from Colombia based on hsp70 gene. <i>Biomedica.</i> 2016; <b>36</b>: 3744. <a target=xrefwindow id=d22068e3355 href="http://www.ncbi.nlm.nih.gov/pubmed/27622623">PubMed Abstract </a> | <a target=xrefwindow id=d22068e3358 href="http://dx.doi.org/10.7705/biomedica.v36i2.2688">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727622367">F1000 Recommendation</a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d22068e3372 class=n-a></a>Roberts WL, McMurray WJ, Rainey PM: Characterization of the antimonial antileishmanial agent meglumine antimonate (glucantime). <i>Antimicrob Agents Chemother.</i> 1998; <b>42</b>(5): 107682. <a target=xrefwindow id=d22068e3380 href="http://www.ncbi.nlm.nih.gov/pubmed/9593130">PubMed Abstract </a> | <a target=xrefwindow id=d22068e3383 href="http://www.ncbi.nlm.nih.gov/pmc/articles/105748">Free Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d22068e3392 class=n-a></a>Vargas-Gonzalez A, Canto-Lara SB, Damian-Centeno AG, <i> et al.</i>: Response of cutaneous leishmaniasis (chiclero's ulcer) to treatment with meglumine antimoniate in Southeast Mexico. <i>Am J Trop Med Hyg.</i> 1999; <b>61</b>(6): 9603. <a target=xrefwindow id=d22068e3403 href="http://www.ncbi.nlm.nih.gov/pubmed/10674678">PubMed Abstract </a> | <a target=xrefwindow id=d22068e3406 href="http://dx.doi.org/10.4269/ajtmh.1999.61.960">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d22068e3415 class=n-a></a>Ypez J, Cazorla D, Snchez de Mirt A, <i> et al.</i>: Effect of intralesional treatment with lidocaine and glucantime in hamsters infected with Leishmania (Viannia) braziliensis. <i>Boletn de la direccin de malariologa y saneamiento ambiental.</i> 1999; <b>39</b>(1): 1020. <a target=xrefwindow id=d22068e3426 href="http://www.worldcat.org/title/effect-of-intralesional-treatment-with-lidocaine-and-glucantime-in-hamsters-infected-with-leishmania-viannia-braziliensis/oclc/71143244">Reference Source</a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d22068e3435 class=n-a></a>Sundar S, Jha TK, Thakur CP, <i> et al.</i>: Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: a multicenter study. <i>Am J Trop Med Hyg.</i> 2002; <b>66</b>(2): 1436. <a target=xrefwindow id=d22068e3446 href="http://www.ncbi.nlm.nih.gov/pubmed/12135284">PubMed Abstract </a> | <a target=xrefwindow id=d22068e3449 href="http://dx.doi.org/10.4269/ajtmh.2002.66.143">Publisher Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d22068e3458 class=n-a></a>Jha TK, Olliaro P, Thakur CP, <i> et al.</i>: Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India. <i>BMJ.</i> 1998; <b>316</b>(7139): 12001205. <a target=xrefwindow id=d22068e3469 href="http://www.ncbi.nlm.nih.gov/pubmed/9583927">PubMed Abstract </a> | <a target=xrefwindow id=d22068e3472 href="http://dx.doi.org/10.1136/bmj.316.7139.1200">Publisher Full Text </a> | <a target=xrefwindow id=d22068e3476 href="http://www.ncbi.nlm.nih.gov/pmc/articles/28521">Free Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d22068e3485 class=n-a></a>Saenz RE, Paz H, Berman JD: Efficacy of ketoconazole against <i>Leishmania braziliensis panamensis</i> cutaneous leishmaniasis. <i>Am J Med.</i> 1990; <b>89</b>(2): 14755. <a target=xrefwindow id=d22068e3496 href="http://www.ncbi.nlm.nih.gov/pubmed/2166429">PubMed Abstract </a> | <a target=xrefwindow id=d22068e3499 href="http://dx.doi.org/10.1016/0002-9343(90)90292-L">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726914764"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22068e3509 class=n-a></a>Prates FV, Dourado ME, Silva SC, <i> et al.</i>: Fluconazole in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis: A Randomized Controlled Trial. <i>Clin Infect Dis.</i> 2017; <b>64</b>(1): 6771. <a target=xrefwindow id=d22068e3520 href="http://www.ncbi.nlm.nih.gov/pubmed/27803094">PubMed Abstract </a> | <a target=xrefwindow id=d22068e3523 href="http://dx.doi.org/10.1093/cid/ciw662">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726914764">F1000 Recommendation</a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d22068e3536 class=n-a></a>Sundar S, Jha TK, Thakur CP, <i> et al.</i>: Oral miltefosine for Indian visceral leishmaniasis. <i>N Engl J Med.</i> 2002; <b>347</b>(22): 173946. <a target=xrefwindow id=d22068e3547 href="http://www.ncbi.nlm.nih.gov/pubmed/12456849">PubMed Abstract </a> | <a target=xrefwindow id=d22068e3550 href="http://dx.doi.org/10.1056/NEJMoa021556">Publisher Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d22068e3559 class=n-a></a>Bhattacharya SK, Jha TK, Sundar S, <i> et al.</i>: Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India. <i>Clin Infect Dis.</i> 2004; <b>38</b>(2): 21721. <a target=xrefwindow id=d22068e3570 href="http://www.ncbi.nlm.nih.gov/pubmed/14699453">PubMed Abstract </a> | <a target=xrefwindow id=d22068e3573 href="http://dx.doi.org/10.1086/380638">Publisher Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d22068e3582 class=n-a></a>Chrusciak-Talhari A, Dietze R, Chrusciak Talhari C, <i> et al.</i>: Randomized controlled clinical trial to access efficacy and safety of miltefosine in the treatment of cutaneous leishmaniasis Caused by <i>Leishmania (Viannia) guyanensis</i> in Manaus, Brazil. <i>Am J Trop Med Hyg.</i> 2011; <b>84</b>(2): 25560. <a target=xrefwindow id=d22068e3596 href="http://www.ncbi.nlm.nih.gov/pubmed/21292895">PubMed Abstract </a> | <a target=xrefwindow id=d22068e3600 href="http://dx.doi.org/10.4269/ajtmh.2011.10-0155">Publisher Full Text </a> | <a target=xrefwindow id=d22068e3603 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3029178">Free Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726737613"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22068e3612 class=n-a></a>Wasunna M, Njenga S, Balasegaram M, <i> et al.</i>: Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial. <i>PLoS Negl Trop Dis.</i> 2016; <b>10</b>(9): e0004880. <a target=xrefwindow id=d22068e3623 href="http://www.ncbi.nlm.nih.gov/pubmed/27627654">PubMed Abstract </a> | <a target=xrefwindow id=d22068e3626 href="http://dx.doi.org/10.1371/journal.pntd.0004880">Publisher Full Text </a> | <a target=xrefwindow id=d22068e3630 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5023160">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726737613">F1000 Recommendation</a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727622368"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22068e3643 class=n-a></a>Mushtaq S, Dogra D, Dogra N: Clinical Response with intralesional Amphotericin B in the treatment of old world cutaneous leishmaniasis: a preliminary report. <i>Dermatol Ther.</i> 2016; <b>29</b>(6): 398405. <a target=xrefwindow id=d22068e3651 href="http://www.ncbi.nlm.nih.gov/pubmed/27477764">PubMed Abstract </a> | <a target=xrefwindow id=d22068e3654 href="http://dx.doi.org/10.1111/dth.12377">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727622368">F1000 Recommendation</a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d22068e3668 class=n-a></a>Croft SL, Yardley V: Chemotherapy of leishmaniasis. <i>Curr Pharm Des.</i> 2002; <b>8</b>(4): 31942. <a target=xrefwindow id=d22068e3676 href="http://www.ncbi.nlm.nih.gov/pubmed/11860369">PubMed Abstract </a> | <a target=xrefwindow id=d22068e3679 href="http://dx.doi.org/10.2174/1381612023396258">Publisher Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d22068e3688 class=n-a></a>Panagiotopoulos A, Stavropoulos PG, Hasapi V, <i> et al.</i>: Treatment of cutaneous leishmaniasis with cryosurgery. <i>Int J Dermatol.</i> 2005; <b>44</b>(9): 74952. <a target=xrefwindow id=d22068e3699 href="http://www.ncbi.nlm.nih.gov/pubmed/16135144">PubMed Abstract </a> | <a target=xrefwindow id=d22068e3702 href="http://dx.doi.org/10.1111/j.1365-4632.2005.02628.x">Publisher Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d22068e3711 class=n-a></a>Weigel MM, Armijos RX: The traditional and conventional medical treatment of cutaneous leishmaniasis in rural Ecuador. <i>Rev Panam Salud Publica.</i> 2001; <b>10</b>(6): 395404. <a target=xrefwindow id=d22068e3719 href="http://www.ncbi.nlm.nih.gov/pubmed/11820108">PubMed Abstract </a> | <a target=xrefwindow id=d22068e3722 href="http://dx.doi.org/10.1590/S1020-49892001001200005">Publisher Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d22068e3731 class=n-a></a>Nelson S, Warschaw K: Chapter 83: Protozoa and Worms. In: Bolognia J, Jorizzo R, Schaffer JV. <i>Dermatology.</i> 3rd Ed. Elsevier-Saunders. New York, 2012; 13911421. </span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 26 May 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-750/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-750/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Secci&oacute;n de Micolog&iacute;a, Hospital &ldquo;Manuel Gea Gonz&aacute;lez&rdquo; Secretar&iacute;a de Salud, Calz. de Tlalpan 4800, Ciudad de M&eacute;xico 14080, Mexico<br/> <sup>2</sup> Dermat&oacute;logo, Cl&iacute;nica Carranza, Chetumal, Quintana Roo, Mexico<br/> <p> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-750/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 26 May 2017, 6:750 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.11120.1">https://doi.org/10.12688/f1000research.11120.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden">  2017 Torres-Guerrero E <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=11996 data-id=11120 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11120.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-750/v1/pdf?article_uuid=484038af-bb9e-47e0-99a1-f63e2d01f75d" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.11120.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Torres-Guerrero E, Quintanilla-Cedillo MR, Ruiz-Esmenjaud J and Arenas R. Leishmaniasis: a review [version 1; peer review: 2 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):750 (<a href="https://doi.org/10.12688/f1000research.11120.1" target=_blank>https://doi.org/10.12688/f1000research.11120.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=11120 id=mobile-track-article-signin-11120 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11120?target=/articles/6-750/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=11996 /> <input name=articleId type=hidden value=11120 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Francisco Bravo-Puccio</strong>, Departments of Pathology and Dermatology, Universidad Peruana Cayetano Heredia, Lima, Peru </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Roderick J Hay</strong>, International Foundation for Dermatology, London, UK; Department of Dermatology, Kings College NHS Trust, London, UK </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 26 May 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-750/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-750/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=23076-23058></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=23075-23059></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-750/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>26 May 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Francisco Bravo-Puccio</strong>, Departments of Pathology and Dermatology, Universidad Peruana Cayetano Heredia, Lima, Peru </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Roderick J Hay</strong>, International Foundation for Dermatology, London, UK; Department of Dermatology, Kings College NHS Trust, London, UK </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-750/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-750/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Leishmaniasis: a review".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-750/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-750/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-750/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Torres-Guerrero E et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-750/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-750",
            templates : {
                twitter : "Leishmaniasis: a review. Torres-Guerrero E et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-750/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Leishmaniasis: a review", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Leishmaniasis: a review", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/11120/11996")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "11996");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "23058": 1,
                           "23059": 1,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "4143f7be-6a11-4ee8-833e-04127ae0a907";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-750.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-750.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-750.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-750.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-750.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>